Introduction {#s1}
============

An important goal for developmental biologists is to understand how organs achieve a predictable size and shape at the end of their development. The Hippo signaling pathway has emerged as a key regulator of organ size (reviewed by [@bib45]; [@bib22]; [@bib62]). While most components of this pathway were originally discovered using genetic screens in *Drosophila*, mammalian orthologs of those genes perform similar functions. Additionally, mutations in several components of the pathway have been described in human cancers. An exciting aspect of the Hippo pathway is that its growth-regulating activity can be modulated by cell-surface proteins that are capable of binding to ligands expressed on adjacent cells. Such interactions may be especially important for achieving precise control of growth at a local level that is necessary for generating the detailed features of an organ.

Of the proteins that regulate the Hippo pathway, much research has focused on the protocadherin Fat (Ft). In addition to regulating growth, Ft also regulates planar cell polarity (PCP), oriented cell division and proximodistal patterning of appendages (reviewed in [@bib64]; [@bib53]) and its regulated activity therefore impacts the size and shape of organs. The Ft protein localizes to the cell membrane just apical to the adherens junctions ([@bib35]). It has a large extracellular domain composed of 34 cadherin domains as well as 4 EGF-like domains and 2 laminin G domains ([@bib36]) that binds to another large cadherin, Dachsous (Ds) ([@bib13]), on adjacent cells ([@bib40]). Ft--Ds interactions are modulated by the kinase Four-Jointed (Fj), which resides in the Golgi and phosphorylates the extracellular domains of both Ft and Ds ([@bib26]; [@bib9]; [@bib56]). Both Ds and Fj are expressed in gradients in *Drosophila* imaginal discs where they function in patterning the disc along a major axis (e.g., equatorial to polar or proximodistal) ([@bib72]; [@bib35]).

While cadherins are known to have important functions in cell--cell adhesion, a key aspect of Ft function is its role as a signaling molecule ([@bib41]). Ft regulates the Hippo pathway in two ways. First, Ft influences the protein levels of Warts (Wts), a kinase that regulates the activity and subcellular location of the pro-growth transcriptional co-activator Yorkie (Yki) ([@bib12]; [@bib50]). Additionally, mutations in *ft* disrupt the localization of Expanded (Ex), a FERM-domain protein that functions upstream of Hippo (Hpo) ([@bib3]; [@bib54]; [@bib68]), though other studies suggest Ft and Ex act in parallel ([@bib17]).

A key downstream target of Ft is the atypical myosin Dachs (D). The strong overgrowth elicited by *ft* mutations can be completely suppressed by loss of D function ([@bib12]). Additionally, PCP defects in *ft* mutants are partially rescued by loss of D ([@bib38]). D localizes to the apical membrane where, in cells of the wing disc, it localizes preferentially to the distal edge of the cell ([@bib38]; [@bib39]; [@bib1]; [@bib6]; [@bib8]). In *ft* mutants, increased levels of D are observed apically and D is redistributed around the entire perimeter of the cell ([@bib38]; [@bib8]). However, the overall levels of D protein are not obviously changed ([@bib38]). It has been proposed that Ft restricts growth by negatively regulating the levels of D at the apical membrane and that it regulates the D-dependent PCP functions by maintaining D asymmetry ([@bib51]).

An important gap in our current understanding of Ft function is how Ft regulates the levels and localization of D at the apical membrane. Ft does not bind to D itself, indicating that there must be one or more proteins that bind to Ft and mediate its regulation of D localization at the membrane. In an attempt to identify signaling pathways downstream of Ft, several recent studies have made systematic deletions in the intracellular domain (ICD) of Ft ([@bib43]; [@bib5]; [@bib46]; [@bib75]). These deletion studies implicate multiple non-overlapping regions in the ICD that differentially affect growth, PCP and organ shape, suggesting that Ft signals via multiple effector pathways. Additionally, several proteins have been shown to bind to the Ft ICD including the transcriptional repressor Atrophin/Grunge which regulates PCP ([@bib16]), the novel protein Lowfat that regulates Ft protein levels ([@bib37]), and the casein kinase I protein Discs overgrown (Dco) that phosphorylates the Ft ICD ([@bib18]; [@bib58]). Also, the palmitoyltransferase approximated (App) is needed for D localization to the membrane ([@bib42]). However, for each of these proteins, their role in mediating the regulation of D levels or asymmetry by Ft is not well understood.

Here we describe the *Drosophila* ortholog of the *Fbxl7* gene, which encodes an F-box protein and is a novel component of the Ft signaling pathway. Inactivation of *Fbxl7* results in increased tissue growth via the Hippo pathway and abnormalities in wing shape and proximodistal patterning of appendages. Fbxl7 localizes preferentially to the proximal edge of cells in the wing pouch where it binds to and co-localizes with Ft. We find a role for Fbxl7 in one of the growth-suppressing signaling pathways downstream of Ft and also demonstrate a role for Fbxl7 in regulating the amount of D at the apical membrane as well as its distribution around the edge of the cell.

Results {#s2}
=======

Fbxl7 functions as a negative regulator of tissue growth and modulates signaling via the Hippo pathway {#s2-1}
------------------------------------------------------------------------------------------------------

In two different genetic screens, one for mutations that caused cells to outgrow their neighbors (described in [@bib63]) and another for mutations that enabled cells to promote the elimination of their slower-growing neighbors by cell competition ([@bib20]), we identified mutant alleles of the *Drosophila Fbxl7* gene (*CG4221*), which encodes a protein with an F-box and 11 leucine-rich repeats (LRRs) ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Fbxl7 has a conserved human ortholog (FBXL7*)* that shares 49% amino acid identity over the region spanning the F-box and the LRRs. Most proteins with these motifs function as part of an SCF-type ubiquitin ligase, a protein complex which polyubiquitylates substrate proteins and targets them for degradation by the proteasome ([@bib57]). A third allele was identified fortuitously in an unrelated stock. Mutant clones of all three alleles were overrepresented in the adult eye when compared to clones of the parental *FRT82B* chromosome ([Figure 1B](#fig1){ref-type="fig"}), suggesting that these *Fbxl7* mutations cause increased tissue growth ([Figure 1C--E](#fig1){ref-type="fig"}). Two of the mutations generate premature stop codons upstream of all conserved domains, while the third causes a cysteine-to-tyrosine change in a conserved residue in one of the LRRs ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1B--C](#fig1s1){ref-type="fig"}) that likely interferes with the normal function of the protein, indicating that all three alleles reduce or eliminate *Fbxl7* function. We also found that a *Mi{MIC}* minos insertion in the first intron of *Fbxl7* ([@bib66]) results in a strong loss-of-function phenotype similar to our other mutant alleles ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}, [Figure 1---figure supplement 2A--B](#fig1s2){ref-type="fig"}).10.7554/eLife.03383.003Figure 1.Fbxl7 negatively regulates growth through the Hippo pathway.(**A**) Protein model of Drosophila Fbxl7 and Human FBXL7 showing the three alleles identified (red asterisks), F-box, and 11 Leucine Rich Repeat (LRR) domains. The two proteins have 49% amino acid identity throughout the F-box and LRR domains. (**B**--**E**) Mosaic adult eye assay. Heterozygous and wild-type cells have red pigment and homozygous mutant cells lack pigment. (**B**) Control mosaic eye. (**C**) *Fbxl7*^*C616Y*^, (**D**), *Fbxl7*^*Q201X*^ and (**E**) *Fbxl7*^*W389X*^ mosaic eyes are composed of more mutant cells. (**F**--**K**) Adult wings with overlays. Arrows indicate anterior and posterior crossveins. Compared to (**F**) *FRT82B* control wings, (**G**) *Fbxl7*^*C616Y*^ homozygous wings are larger and crossveins are closer. (**H**) Merge shows **F** in blue and **G** in red. Compared to (**I**) *nubbin-Gal4 (nb-Gal4)* control wings, (**J**) *nb\>FLAG-Fbxl7* overexpressing wings are smaller and crossveins are closer. (**K**) Merge shows **I** in blue and **J** in red. (**L**) Quantification of wing area from *Fbxl7* loss-of-function, RNAi (*JF01515*), and overexpression. n ≥ 20 wings, \*\*\*p ≤ 0.001, error bars show SD. (**M**--**M″**) Cell competition assay in the mosaic eye imaginal disc. (**M**) Wild-type cells are marked by GFP (green), while *Fbxl7* mutant cells are GFP negative. (**M′**) Activated caspase-3 (red) is detected in dying cells that are GFP positive (arrows). (**M″**) DAPI shows all nuclei. (**N**--**N″**) Mosaic eye imaginal disc with *diap1-GFP* (green) reporter. (**N**--**N′**) Wild-type cells are marked with RFP (red) and *Fbxl7* mutant cells are RFP negative. (**N″**) Mutant clones show higher levels of *diap1-GFP* (arrows). (**O--O′**) Mosaic wing imaginal disc with *ex-lacZ* reporter (red). A clone overexpressing FLAG-Fbxl7 (green, cells marked by EGFP) has lower levels of *ex-lacZ* (arrow). (**P**--**R**) Wing size genetic interaction assay. Compared to (**P**) *nb\>Fbxl7*^*XP*^ alone, (**Q**) reducing the dosage of *wts* partially rescues the small wing phenotype. (**R**) Merge shows **P** blue and **Q** in red.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.003](10.7554/eLife.03383.003)10.7554/eLife.03383.004Figure 1---figure supplement 1.Fbxl7 gene and protein models.(**A**) *Fbxl7* gene model. *CG4221-RA* is the only predicted isoform. Thin black lines are introns, gray boxes indicate non-coding exons, and blue boxes indicate coding exons. *CG34276* is located in the first intron of *Fbxl7*. *P{XP}d08178* is inserted immediately upstream of the *Fbxl7* transcript and contains UAS sequences to drive ectopic expression of *Fbxl7. Mi{MIC}MI04292* is inserted in the first intron of *Fbxl7*. (**B**) Fbxl7 protein alignment of Drosophila Fbxl7 (NP_650512.1), Human FBXL7 (NP_036436.1), Mouse FBXL7 (NP_795933.2), and Zebrafish Fbxl7 (NP_001073511.1). Alignment performed with Clustal Omega and exported with Jalview software. Conserved F-box domains are shown in green and 11 Leucine Rich Repeat (LRR) domains are shown in yellow. Drosophila *Fbxl7* mutations indicated in red. (**C**) Alignment of Cys-containing LRR subfamily domains from Drosophila Fbxl7, Human FBXL7, and *S. cerevisiae* Grr1 (NP_012623.1). LRRs identified using SMART software ([@bib34]). Black box indicates the Drosophila Fbxl7^C616Y^ amino acid mutation that affects a conserved cysteine. Structural model shows the predicted LRR β-sheet (arrow) and α-helix (helix) modeled after ([@bib24]). Consensus sequence definitions according to [@bib2] and [@bib32].**DOI:** [http://dx.doi.org/10.7554/eLife.03383.004](10.7554/eLife.03383.004)10.7554/eLife.03383.005Figure 1---figure supplement 2.Additional Fbxl7 mutant phenotypes.(**A**--**B**) Quantification of adult wing area and cross vein distance for different *Fbxl7* loss of function and overexpression phenotypes. n ≥ 10 wings. Significance calculated with 1way ANOVA followed by Tukey\'s test. \*\*\*p ≤ 0.001, \*p ≤ 0.05. Error bars indicate SD. (**C**--**D**) Adult male prothoracic legs from control or overexpressing *FLAG-Fbxl7.* Black bracket shows shortening of tibia and tarsus segments. (**E**--**J**) Wing hair polarity in the region between veins L3 and L4 and proximal to the anterior cross vein (black box in **E**). (**J**) Overexpressing *fat* causes wing hairs to change direction (yellow arrowhead). (**K**--**L**) Increased adult wing size from RNAi knockdown of Fbxl7 in the wing is enhanced by *wts* heterozygosity. Merge shows **K** in blue and **L** in red. (**M**--**O**) Confocal slices of imaginal discs with clones overexpressing *FLAG-Fbxl7* and assessing Hippo pathway reporters *ex-lacZ* and *Tub-EGFP.ban* ('*bantam sensor*'). ex-lacZ positively reports Yki activity, whereas *bantam-sensor* inversely reports *bantam* activity (*bantam*, a microRNA, is a transcriptional target of Yki). (**M**--**N**) Cells overexpressing FLAG-Fbxl7 (marked by EGFP, green) have lower levels of *ex-lacZ* (red), and neighboring wild-type cells have higher levels of ex-lacZ (arrowhead). (**O**) Cells overexpressing FLAG-Fbxl7 (marked by myr-RFP, red) have higher levels of *bantam-sensor* (green), and neighboring wild-type cells have lower levels of *bantam-sensor* (yellow arrowhead).**DOI:** [http://dx.doi.org/10.7554/eLife.03383.005](10.7554/eLife.03383.005)

Although clones of mutant cells display a clear growth advantage, flies homozygous for each of these *Fbxl7* mutations are viable and fertile. However, the wings of *Fbxl7* homozygotes or hemizygotes (*Fbxl7*^*-*^/Deficiency) are larger and more rounded than wild-type wings ([Figure 1F--H](#fig1){ref-type="fig"}; quantified in [Figure 1L](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}) and the distance between the cross veins is reduced ([Figure 1F--G](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). The same alterations in wing area and spacing between the cross veins were also observed when *Fbxl7* function was reduced by RNAi ([Figure 1L](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2A--B](#fig1s2){ref-type="fig"}) ([@bib15]). The combination of overgrowth and reduced spacing of the cross veins is especially reminiscent of mutations in the Ft branch of the Hippo signaling pathway ([@bib10]; [@bib36]; [@bib13]; [@bib67]; [@bib38]; [@bib42]; [@bib37]).

Since we identified one of the *Fbxl7* alleles in a screen for mutations that made cells capable of eliminating their neighbors ([@bib20]), we examined imaginal discs for evidence of cell death. We observed elevated levels of activated caspase-3, a marker of apoptosis, especially in wild-type cells adjacent to *Fbxl7* mutant clones ([Figure 1M--M″](#fig1){ref-type="fig"}). Thus *Fbxl7* mutant cells do indeed behave as supercompetitors similar to loss-of-function mutations in *ft* or in core components of the Hippo pathway such as *hpo* or *wts* ([@bib65]).

Reduced signaling via the Hippo pathway results in increased activity of the transcriptional co-activator Yki. In *Fbxl7* mutant clones in the eye imaginal disc, expression of a *diap1-GFP* reporter gene ([@bib74]) was increased, especially posterior to the morphogenetic furrow ([Figure 1N--N″](#fig1){ref-type="fig"}) consistent with increased Yki activity. Additionally, the enlarged wing phenotype observed upon expression of *Fbxl7*^*RNAi*^ was enhanced by heterozygosity of the *wts*^*X1*^ allele ([Figure 1---figure supplement 2K--L](#fig1s2){ref-type="fig"}). Together these results indicate that loss of *Fbxl7* leads to increased growth via the Hippo pathway.

When we overexpressed *Fbxl7* in the wing imaginal disc, the adult wings were smaller and had a reduced distance between the cross veins ([Figure 1I--L](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2A--B](#fig1s2){ref-type="fig"}). Overexpressing Fbxl7 also reduced the length of distal leg segments ([Figure 1---figure supplement 2C--D](#fig1s2){ref-type="fig"}). Results were similar using either a *UAS-Fbxl7* transgene or a *P\[XP\]* transposon which contains UAS sequences upstream of the endogenous *Fbxl7* transcriptional start site ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). This reduction in wing size was suppressed by heterozygosity of the *wts*^*X1*^ allele ([Figure 1P--R](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). When we overexpressed a form of *Fbxl7* bearing the missense mutation identified in the screen, *Fbxl7*^*C616Y*^, there was, if at all, a slight increase in wing size ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}) suggesting that this mutation disrupts the normal function of the protein and likely functions as a dominant-negative mutation at least under conditions of overexpression.

Since increased signaling via the Hippo pathway would reduce Yki activity, we examined expression of Yki reporters. Overexpression of *Fbxl7* reduced expression of an *ex-lacZ* reporter ([@bib4]; [@bib23]) in a cell-autonomous manner ([Figure 1O--O′](#fig1){ref-type="fig"}). However, wild-type cells close to the *Fbxl7*-overexpressing cells had increased *ex-lacZ* reporter expression, especially in the notum of the wing disc and in the eye disc ([Figure 1---figure supplement 2M--N′](#fig1s2){ref-type="fig"}). A similar phenomenon was observed with the *bantam* sensor ([Figure 1---figure supplement 2O--O′](#fig1s2){ref-type="fig"}) ([@bib7]), which is expressed at higher levels when Yki activity is reduced. This non-autonomous increase in Yki activity is similar to that seen when Ft is overexpressed ([@bib43]) or at boundaries of differential Ds or Fj activity ([@bib69]). Taken together, these results indicate that Fbxl7 functions as a negative regulator of growth via the Hippo pathway. Moreover, the multiple phenotypic similarities between alterations in Ft levels and Fbxl7 levels suggest that Fbxl7 functions in proximity to Ft.

Fbxl7 localizes to the apical membrane and is distributed asymmetrically {#s2-2}
------------------------------------------------------------------------

A polyclonal antibody to an N-terminal portion of Fbxl7 detects uniform Fbxl7 expression throughout the wing imaginal disc ([Figure 2A](#fig2){ref-type="fig"}), with a slight enrichment at the dorsal-ventral boundary in the pouch as is also observed for Ft protein ([@bib37]). At the cellular level, punctate staining is observed outlining the apical profiles of cells, which is absent in homozygous mutant clones of the *Fbxl7*^*Q201X*^ allele ([Figure 2B--B′](#fig2){ref-type="fig"}) indicating that the truncated protein generated by this allele is likely unstable. In *Fbxl7*^*C616Y*^ clones, apical puncta are absent but cytoplasmic staining is observed above background levels, indicating that the mutant protein is present but does not localize apically (not shown). An Fbxl7 protein with an N-terminal FLAG epitope tag (FLAG-Fbxl7) exhibits an apical localization that is very similar to that of the endogenous protein ([Figure 2C--F](#fig2){ref-type="fig"}). Using either the anti-Fbxl7 antibody ([Figure 2C,E](#fig2){ref-type="fig"}) or FLAG-Fbxl7 ([Figure 2D,F](#fig2){ref-type="fig"}), we found that Fbxl7 localizes to the subapical region of cells, apical to the adherens junctions marked by E-cadherin. FLAG-Fbxl7 is also found in intracellular puncta ([Figure 2G](#fig2){ref-type="fig"}). In contrast, FLAG-Fbxl7 protein bearing the C616Y missense mutation displays only diffuse cytoplasmic localization ([Figure 2H](#fig2){ref-type="fig"}) suggesting that the normal function of Fbxl7 may be contingent upon its localization to the apical region or cytoplasmic puncta. In *Drosophila* S2 cells (not shown) or the flattened cells of the peripodial epithelium ([Figure 2I](#fig2){ref-type="fig"}), confocal sections show puncta with diameters typically in the range of 400--500 nm (some as large as 1000 nm) with a hollow interior, consistent with the possibility that these might be vesicles.10.7554/eLife.03383.006Figure 2.Fbxl7 is localized to apical membrane, cytoplasmic puncta, and the proximal side of planar polarized cells.Confocal slice of (**A**) endogenous Fbxl7 and (**A′**) Armadillo (Arm) in the wing imaginal disc. Arrow indicates enrichment of Fbxl7 at the dorso-ventral boundary. (**B**--**B′**) A confocal slice through the apical surface of wing disc cells. Fbxl7 (red) accumulates at the apical membrane and is lost from MARCM *Fbxl7*^*Q201X*^ clones (green). (**C**--**F**) Endogenous Fbxl7 and expressed FLAG-Fbxl7 (green) are localized to apical puncta aligned with cell edges marked by E-cadherin (E-cad) (red). (**C**--**D**) Confocal slices through the apical surface of wing disc cells. (**E**--**F**) Confocal slice through folds in the wing disc. Fbxl7 is apical to E-cad (arrowheads). (**F**) Asterisk indicates adjacent fold that does not express FLAG-Fbxl7. (**G**--**H**) Confocal Z-slice through the wing disc with clones of cells expressing FLAG-Fbxl7 or FLAG-Fbxl7^C616Y^ (green). Nuclei are shown with DAPI (blue). (**G**) FLAG-Fbxl7 localizes to apical membrane (arrowhead) and cytoplasmic puncta (arrows), whereas (**H**) FLAG-Fbxl7^C616Y^ shows diffuse cytoplasmic localization. (**I**) Confocal section through peripodial membrane showing FLAG-Fbxl7 localization to hollow puncta. Inset shows higher magnification of outlined box. (**J**--**K‴**) Confocal slice of the wing disc pouch stained for E-cad (red) with clones expressing FLAG-Fbxl7 (green). (**K**--**K″**) Magnified region from box in **J**, showing FLAG-Fbxl7 enriched on proximal membrane (arrowheads). (**K‴′'**) Magnified region from box in **K‴**. D = distal, P = proximal.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.006](10.7554/eLife.03383.006)

In cells of the wing imaginal disc, Ft is preferentially expressed on the proximal side of cells and Ds and D on the distal surface ([@bib1]; [@bib8]). We generated small clones that expressed FLAG-Fbxl7, which enabled us to examine the borders between FLAG-Fbxl7-expressing cells and wild-type cells. In the dorsal part of the wing pouch, where polarization of D is most evident ([@bib8]), FLAG-Fbxl7 localizes preferentially to the proximal side of cells ([Figure 2J,K--K‴](#fig2){ref-type="fig"}).

Fbxl7 associates with Ft and regulates its localization {#s2-3}
-------------------------------------------------------

Since the localization of Fbxl7 is similar to that described for Ft, we examined whether the two proteins co-localize. Both anti-Fbxl7 and anti-Ft revealed apical staining in a punctate manner with a considerable degree of overlap ([Figure 3A--A″](#fig3){ref-type="fig"}). Additionally, we observed co-localization of FLAG-Fbxl7 and Ft at the apical membrane ([Figure 3B--B″](#fig3){ref-type="fig"}) as well as in cytoplasmic puncta ([Figure 3B″--B‴](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}), many of which were basally located. Higher gain settings were required to visualize the comparatively faint Ft staining in puncta ([Figure 3B‴′](#fig3){ref-type="fig"}). Because of a higher background level of cytoplasmic staining with anti-Fbxl7, the FLAG-tagged Fbxl7 protein was necessary to observe co-localization in puncta.10.7554/eLife.03383.007Figure 3.Fbxl7 physically interacts with Fat and regulates its apical localization.(**A**--**A″**) Confocal slice through a wing disc fold showing endogenous Fbxl7 (green) and Fat (red) co-localize at apical membrane (arrowhead). (**B**--**B‴′**) Confocal Z-section showing FLAG-Fbxl7 (green) and Fat (red) co-localize at (**B**--**B″**) apical membrane (arrowhead) and (**B″**--**B‴′**) cytoplasmic puncta (arrows). (**B″**--**B‴′**) Inset shows magnification of puncta. **B‴′** uses higher gain settings than **B′** to visualize Fat in puncta. (**C**) Co-immunoprecipitation experiment in S2 cells. FatICD-V5 pulls down with FLAG-Fbxl7, whereas pulldown is reduced with FLAG-Fbxl7^C616Y^. (**D**--**D‴**) Confocal slice of the wing disc at the apical surface. Apical Fbxl7 (red) localization is lost from MARCM *fat*^*Grv*^ clones (green), whereas (**D′**) E-cad (blue) localization is unchanged. (**D‴**) shows magnification of the box in **D**. (**E**--**E‴**) A basal confocal slice through the same clone in **D**, showing increased cytoplasmic levels of Fbxl7. (**F**--**F″**) Confocal slice through a fold showing a MARCM *fat*^*Grv*^ clone (GFP marker not shown) which expresses FLAG-Fbxl7 (anti-Flag, green). (**F′**) E-cad (red) marks apical membrane. FLAG-Fbxl7 is not apically localized in *fat*^*Grv*^ clones (arrowhead), but does localize to cytoplasmic puncta (arrows). (**G**--**G′**) Confocal slice through the apical surface of a disc overexpressing FLAG-Fbxl7 (green) in clones. (**G′**) Apical Fat (red) levels are elevated within the clone. (**H**--**H″**) Confocal slice through the apical surface with a MARCM *Fbxl7*^*Q201X*^ clone (green) showing (**H′**) no change in levels of apical E-cad (blue) and (**H″**) slightly elevated levels of apical Fat (red).**DOI:** [http://dx.doi.org/10.7554/eLife.03383.007](10.7554/eLife.03383.007)10.7554/eLife.03383.008Figure 3---figure supplement 1.Additional analysis of the relationship between Fbxl7 and Fat.(**A**) A confocal z-section through a wing disc with clones overexpressing FLAG-Fbxl7 and staining for FLAG (green) and Fat (red). Apical membrane is towards the top of the image. Fat and FLAG-Fbxl7 colocalize at apical membrane (yellow arrowhead). (**A‴**--**A‴′**) Higher gain settings to observe Fat cytoplasmic punctae and heat map of fluorescence intensity. Fat localizes to punctae in both wild-type cells and FLAG-Fbxl7 expressing cells (yellow arrows). Cytoplasmic Fat is slightly elevated in FLAG-Fbxl7 expressing cells. (**B**) Schematics of FLAG-Fbxl7 truncation constructs. (**C**) Western blots showing results of co-immunoprecipitation experiments from S2 cells expressing indicated transfected plasmids. FatICD co-immunoprecipitates with full length FLAG-Fbxl7 as well as the LRR domain. The Fbxl7^C616Y^ protein reduces association with FatICD. The N-terminal domain of Fbxl7 can weakly associate with FatICD. FLAG-Fbxl7Δ3 protein is found at higher levels than other Fbxl7 proteins despite transfecting the same amount of plasmid and loading the same amount of total protein. (**D**) Western blots showing endogenous Fat protein from wing disc lysates of indicated genotypes. The asterisk indicates higher molecular weight Fat in discs overexpressing FLAG-Fbxl7.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.008](10.7554/eLife.03383.008)

To determine whether Ft and Fbxl7 can interact physically, we co-transfected S2 cells with tagged versions of Fbxl7 and a portion of Ft that includes the transmembrane domain and the entire intracellular domain (FatICD). FatICD co-immunoprecipitates with FLAG-Fbxl7, whereas association of FatICD with FLAG-Fbxl7^C616Y^ is greatly reduced ([Figure 3C](#fig3){ref-type="fig"}). We also examined the ability of truncated Fbxl7 proteins to interact with Ft and find that Fbxl7 interacts with Ft mostly via its LRRs ([Figure 3---figure supplement 1B--C](#fig3s1){ref-type="fig"}). A weaker interaction is also observed between Ft and the N-terminal portion of Fbxl7. Thus wild-type Fbxl7 can associate, either directly or indirectly, with the intracellular domain of Ft and this interaction mostly occurs via the LRRs of Fbxl7.

The apical localization of Fbxl7 was absent in *ft* clones ([Figure 3D--D‴](#fig3){ref-type="fig"}). However, an increase in diffuse cytoplasmic staining was observed ([Figure 3E--E‴](#fig3){ref-type="fig"}). Thus the localization of Fbxl7 to the apical region is dependent upon Ft and in the absence of Ft, Fbxl7 re-localizes to the cytoplasm. Since Ft and Fbxl7 also co-localize to cytoplasmic puncta or vesicles, we examined whether this localization of Fbxl7 also depends on Ft. Surprisingly, unlike the apical localization, punctate localization of FLAG-Fbxl7 was still observed in *ft* clones indicating that the localization of Fbxl7 in these cytoplasmic puncta is independent of Ft ([Figure 3F--F″](#fig3){ref-type="fig"}).

Since proteins similar to Fbxl7 often bind to their substrates via their LRRs and promote their polyubiquitylation and degradation ([@bib57]), we tested the effect of changes in Fbxl7 on the levels and localization of Ft. Increasing Fbxl7 levels resulted in clearly increased levels of apical Ft ([Figure 3G--G′](#fig3){ref-type="fig"}) and slightly increased cytoplasmic staining of Ft ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Surprisingly, a slight elevation of apical Ft levels was also observed in *Fbxl7* mutant clones ([Figure 3H--H″](#fig3){ref-type="fig"}). The overall levels of Ft protein in imaginal discs, as assessed by Western blotting, were not obviously changed in either case ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}). These results are inconsistent with Fbxl7 promoting Ft degradation and instead suggest that Fbxl7 regulates Ft localization. In support of this, we do not observe an obvious increase in Ft ubiquitylation from expressing Fbxl7 in S2 cells (not shown).

The apical localization of Fbxl7 does not require Ds or Dco {#s2-4}
-----------------------------------------------------------

Since the phenotypic abnormalities of *Fbxl7* mutants resemble those of hypomorphic alleles of *ft*, and the recruitment of Fbxl7 to the apical region of the cell is dependent upon Ft, we explored the relationship between Fbxl7 and proteins known to regulate Ft in more detail. In *ds* mutant clones, apical localization of Fbxl7 is no longer observed as discrete puncta at cell edges but is rather more diffuse ([Figure 4A--A″](#fig4){ref-type="fig"}). Moreover, in contrast to *ft* clones, we do not see an increase in cytoplasmic Fbxl7 in *ds* clones at more basal focal planes, indicating that Fbxl7 is still predominantly at an apical location ([Figure 4B--B″](#fig4){ref-type="fig"}). These changes in Fbxl7 localization could simply be a consequence of the more diffuse localization of Ft that is observed in *ds* clones ([@bib60]; [@bib35]; [@bib37]). Fj is required for normal localization of Ds and Ft ([@bib60]; [@bib35]). In agreement with this, we see subtle effects on Fbxl7 localization in *fj* clones, which appears similar to that seen in *ds* clones ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}).10.7554/eLife.03383.009Figure 4.Relationship between Fbxl7 and the Fat pathway proteins Ds and Dco.(**A--A″**) Confocal slice through the apical surface of a disc with MARCM *ds*^*38k*^ clones (green) showing disturbed localization of Fbxl7 (red). E-cad staining is not altered (blue) (**B**--**B″**) A basal confocal slice through the same clone in **A**, showing no change in Fbxl7 cytoplasmic levels. (**C**--**E″**) Confocal slice through the apical surface of a disc with FLAG-Fbxl7 overexpressing clones (green) and stained for Ds (red). (**C**--**D″**) Apical Ds levels appear higher and more punctate in FLAG-Fbxl7 expressing clones. Wild-type cells immediately adjacent to the clone have reduced apical Ds (arrowheads). (**E**--**E″**) Ds and FLAG-Fbxl7 puncta are aligned on either side of the clone boundary (arrowheads). (**F**--**F″**) Apical confocal slice of a disc containing MARCM *Fbxl7*^*Q201X*^ clones (green) and stained for Ds (red) and E-cad (blue). Ds levels are normal or slightly elevated, in clones. (**G**--**G″**) Confocal Z-section of a clone expressing FLAG-Fbxl7 (green) and stained for Ds (red). Both are localized to apical membrane (arrowhead) and frequently co-localize in cytoplasmic puncta (arrows). (**H**--**I″**) Apical confocal slice of MARCM *dco*^*3*^ or *dco*^*le88*^ clones (green) and staining for Fbxl7 (red) and E-cad (blue). Apical Fbxl7 levels are unchanged in (**H**--**H″**) *dco*^*3*^ and (**I**--**I″**) *dco*^*le88*^ clones. (**J**) Co-immunoprecipitation experiment in S2 cells. Dco-V5 pulls down with FLAG-Fbxl7, whereas pulldown is reduced with FLAG-Fbxl7^C616Y^.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.009](10.7554/eLife.03383.009)10.7554/eLife.03383.010Figure 4---figure supplement 1.Additional analysis of the relationship between Fbxl7 and Fat pathway proteins.(**A**) Confocal slice through the apical membrane of wing disc cells bearing MARCM *fj*^*N7*^ clones (green) and antibody stained for Fbxl7 (red) and E-cad (blue). Fbxl7 apical localization is partially disrupted. (**B**--**C″**) Confocal slices through the apical membrane of wing disc cells bearing MARCM clones (green) and antibody stained for Fbxl7 (red) and E-cad (blue). Fbxl7 apical localization is normal in (**B**--**B″**) *dachs*^*GC13*^ or (**C**--**C″**) *wts*^*X1*^ clones.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.010](10.7554/eLife.03383.010)

When Fbxl7 is overexpressed in clones, cells have more prominent apical expression of Ds in puncta ([Figure 4C--C″](#fig4){ref-type="fig"}). Additionally, in wild-type cells bordering the Fbxl7-overexpressing clone, Ds staining is reduced and accumulates in prominent puncta at the surface that abuts the Fbxl7-overexpressing cells ([Figure 4D--E″](#fig4){ref-type="fig"}). Given that Ds can be drawn toward cells with greater levels of Ft ([@bib35]), Ds may be drawn toward Fbxl7-overexpressing cells due to the increased Ft levels. Furthermore, the puncta of Ds in adjacent wild-type cells are in register with Fbxl7 puncta, consistent with the coupling of Ds in wild-type cells to Fbxl7-bound Ft within the clone. In *Fbxl7* mutant clones, there is, at best, a very slight elevation of Ds levels ([Figure 4F--F″](#fig4){ref-type="fig"}). Thus, the effects of Fbxl7 on Ds levels are minor compared to the effects on Ft levels. Additionally, we could not detect Ds in immunoprecipitates of Fbxl7 when the two proteins were co-expressed in S2 cells (not shown). Together, these findings suggest that Fbxl7 binds to and functions with Ft rather than Ds. Despite this, we did observe co-localization of Fbxl7 and Ds at apical membranes and in more basally located cytoplasmic puncta ([Figure 4G--G″](#fig4){ref-type="fig"}). In the absence of evidence for direct interactions between Fbxl7 and Ds, their co-localization, at least at the cell surface, may result from Fbxl7 bound to Ft that is in turn bound to Ds.

Ds binding to Ft induces the phosphorylation of the ICD of Ft, which requires the protein kinase, Dco ([@bib18]; [@bib58]). Since some F-box proteins bind to phosphorylated proteins ([@bib57]), we tested whether the apical localization of Fbxl7 was dependent upon Dco function. The apical localization of Fbxl7 was not obviously changed in clones of the *dco*^*3*^ allele that is unable to phosphorylate Ft ([Figure 4H--H″](#fig4){ref-type="fig"}) ([@bib58]). While Dco is capable of binding to Fbxl7 as assessed by co-immunoprecipitation from S2 cells ([Figure 4J](#fig4){ref-type="fig"}), the apical localization of Fbxl7 was still observed in clones of the null *dco* allele, *dco*^*le88*^ ([Figure 4I--I″](#fig4){ref-type="fig"}), thus indicating that Dco function is altogether unnecessary for the apical localization of Fbxl7.

Furthermore, while changes in Fbxl7 alter Hippo signaling, changes in Hippo signaling do not regulate Fbxl7 levels or localization, as Fbxl7 localization is normal in clones mutant for *dachs* or *wts* ([Figure 4---figure supplement 1B--C″](#fig4s1){ref-type="fig"}).

Fbxl7 functions in one of two growth-suppressing pathways downstream of Ft {#s2-5}
--------------------------------------------------------------------------

The primary amino acid sequence of the ICD of Ft does not predict any domains with enzymatic activity or known protein--protein interaction motifs. Hence, it has not been easy to understand how it functions in signal transmission. However, six blocks of sequence (labeled A--F in [Figure 5A](#fig5){ref-type="fig"} based on the nomenclature of [@bib46]) are conserved with the ICD of mammalian Fat4. A region between the conserved blocks 'B' and 'C' seems necessary for the major growth-suppressive function of Ft ([@bib43]; [@bib5]; [@bib75]). In our screen, we identified an allele of *ft*, *ft*^*61*^ ([Figure 5A](#fig5){ref-type="fig"}), which displays strong overgrowth ([Figure 5C,K](#fig5){ref-type="fig"}) and is caused by a single amino acid change (T to I) within this region. *ft*^*61*^ displays phenotypic abnormalities that are very similar to those described for *ft*^*sum*^, which also changes a single amino acid two residues N-terminal to *ft*^*61*^ ([@bib5]). Additionally, in a *ft* null background, deletion of one of the conserved blocks (block D in [Figure 5A](#fig5){ref-type="fig"}) in a *ft* genomic rescue transgene was shown to cause overgrowth ([@bib46]) albeit to a much lesser extent than for *ft*^*61*^ and *ft*^*sum*^; flies had slightly overgrown, rounder wings with decreased spacing between the crossveins ([Figure 5E](#fig5){ref-type="fig"}).10.7554/eLife.03383.013Figure 5.Fbxl7 functions in one of two growth-suppressing pathways downstream of Ft.(**A**) Protein model of the intracellular domain of Fat showing the transmembrane domain (TM), regions conserved with mammalian Fat4 (blue, A--F) (defined by [@bib46]), regions associated with the major growth suppressive function of Fat (red) (HM, [@bib5]; Hippo-N, Hippo-C, [@bib43]; H2, [@bib75]), region required for Dco binding (green) ([@bib58]), mutV region (orange) ([@bib46]), Su(DN) region (purple) ([@bib43]), and two point mutations, *ft*^*sum*^ ([@bib5]) and *ft*^*61*^ (this study). Size and position of regions are drawn to scale relative to the ICD. (**B**--**C**) Mosaic adult eye assay. Heterozygous wild-type cells have red pigment and homozygous mutant cells lack pigment. Compared to (**B**) control *FRT40A* mosaic eyes, (**C**) *ft*^*61*^ mosaic eyes are larger and have more mutant tissue. (**D**) *ft*^*Grv*^/*ft*^*8*^; *ft*^*+*^ adult wing and (**D′**--**D‴**) confocal slice of a wing disc showing that Fbxl7 (red) is localized to the apical membrane similar to E-cad (green). (**E**) *ft*^*Grv*^/*ft*^*8*^; *ftΔD* adult wing and (**E′**--**E‴**) confocal slice showing that Fbxl7 (red) apical localization is disrupted. (**F**) *ft*^*Grv*^/*ft*^*8*^; *ftΔF* adult wing and (**F′**--**F‴**) confocal slice showing that Fbxl7 (red) apical localization is normal and similar to that in **D′**--**D‴**. (**G**) Confocal slice of a disc containing a MARCM *ft*^*61*^ clone (green) and stained for Fbxl7 (red) and E-cad (blue). Fbxl7 apical localization is normal in *ft*^*61*^ cells (**H**) Co-immunoprecipitation experiment in S2 cells. Fat-V5, Fat^61^-V5, and FatΔF-V5 pull down with FLAG-Fbxl7, whereas pull down of FatΔD-V5 and FatmutV-V5 is reduced. Expressed Fat proteins contain only transmembrane and cytoplasmic regions (ICD). (**I**--**M**) Wing imaginal discs (and associated leg and haltere discs) at low magnification. Compared to (**I**) control *tub-Gal4* discs, (**J**) *ft*^*Grv*^/*ft*^*8*^ and (**K**) *ft*^*61*^/*ft*^*8*^ discs are larger and have more folds. (**L**) Ubiquitous expression of Fbxl7 does not rescue *ft*^*Grv*^/*ft*^*8*^ disc overgrowth. (**M**) Ubiquitous expression of Fbxl7 rescues disc overgrowth of *ft*^*61*^/*ft*^*8*^. (**N**--**O**) Adult wing from (**N**) control *tub-Gal4* and (**O**) ubiquitous expression of FLAG-Fbxl7 in an *ft*^*61*^/*ft*^*8*^ background. Animal lethality is rescued. (**P**--**Q′**) Confocal slice through the eye imaginal disc showing MARCM clones (green) and anti-Diap1 staining (red). (**P**--**P′**) *dco*^*3*^ clones have elevated Diap1 levels and are overgrown, whereas (**Q**--**Q′**) *dco*^*3*^ clones expressing FLAG-Fbxl7 have wild-type Diap1 levels and are reduced in size.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.013](10.7554/eLife.03383.013)10.7554/eLife.03383.014Figure 5---figure supplement 1.Additional images of Fbxl7 localization in Fat deletion backgrounds.Confocal sections of wing disc cells stained with anti-Fbxl7 (red) and anti-E-cad (green) in different *ft* genetic backgrounds. (**A**--**A″**, **C**--**C″**, **E**--**E″**, **G**--**G″**) show apical sections and (**B**--**B″**, **D**--**D″**, **F**--**F″**, **H**--**H″**) show z-sections. (**A**--**B″**) *ft*^*Grv*^/*ft*^*8*^, (**C**--**D″**) *ft*^*Grv*^/*ft*^*8*^; *ft*^*+*^, (**E**--**F″**) *ft*^*Grv*^/*ft*^*8*^; *ftΔD*, (**G**--**H″**) *ft*^*Grv*^/*ft*^*8*^; *ftΔF*. Arrows indicate location of apical membrane. Fbxl7 apical localization is lost in *ft*^*Grv*^/*ft*^*8*^; *ftΔD*.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.014](10.7554/eLife.03383.014)10.7554/eLife.03383.015Figure 5---figure supplement 2.Domain D of Ft is required for the effects of Fbxl7 on Ft localization.Confocal projection of apical membrane in wing disc cells stained for anti-V5 (red) with clones overexpressing FLAG-Fbxl7 (green, marked by GFP) in different genetic backgrounds. Ft proteins are N-terminally tagged with V5. (**A**--**A′**) V5-Ft+, (**B**--**B′**) V5-FtΔD, (**C**--**C′**) V5-FtΔF. Arrows indicate edge of clones. Apical levels of V5-FtΔD protein are not increased upon Fbxl7 overexpression.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.015](10.7554/eLife.03383.015)10.7554/eLife.03383.016Figure 5---figure supplement 3.Additional characterization of Fbxl7 rescue experiments.(**A**--**G**) Wing imaginal discs (and associated leg and haltere discs) at low magnification. Expanded set of panels compared to Figure **I**--**M**. Compared to (**A**) control *tub-Gal4* discs, (**B**) *ft*^*Grv*^/*ft*^*8*^ and (**C**) *ft*^*61*^/*ft*^*8*^ discs are larger and have more folds. (**D**) Ubiquitous expression of Fat rescues *ft*^*Grv*^/*ft*^*8*^ disc overgrowth. (**E**) Ubiquitious expression of Fbxl7 does not obviously change disc size from wild type. (**F**) Ubiquitous expression of Fbxl7 does not rescue *ft*^*Grv*^/*ft*^*8*^ disc overgrowth. (**G**) Ubiquitous expression of Fbxl7 rescues disc overgrowth of *ft*^*61*^/*ft*^*8*^. (**H**--**K**) Adult wings. (**H**) Control adult *tub-Gal4* wing. (**I**) Ubiquitous expression of Fat can rescue *ft*^*Grv*^ *ft*^*8*^ animal lethality. (**J**) Ubiquitous expression of Fbxl7 does not affect viability and wings are smaller. (**K**) Ubiquitous expression of Fbxl7 rescues animal lethality of *ft*^*61*^/*ft*^*8*^. (**L**--**O′**) Confocal slice through the eye imaginal disc showing MARCM clones (green) (arrowheads) and anti-Diap1 staining (red). (**L**--**L′**) *wts*^*X1*^ clones have elevated Diap1 levels and are overgrown. (**M**--**M′**) Expressing FLAG-Fbxl7 in *wts*^*X1*^ clones does not effect the elevated Diap1 levels or overgrowth. (**N**--**N′**) *dco*^*3*^ clones have elevated Diap1 levels and are overgrown, whereas (**O**--**O′**) *dco*^*3*^ clones expressing FLAG-Fbxl7 have wild-type Diap1 levels are reduced in size.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.016](10.7554/eLife.03383.016)

In contrast to null alleles of *ft,* which display strong overgrowth and cause lethality well before the adult stage, flies lacking *Fbxl7* function are viable and fertile but have slightly overgrown wings that are rounded and have decreased spacing between the cross veins. Thus, their phenotypic abnormalities are very similar to those observed when the *ft* D region is deleted (*ftΔD)*. We therefore examined the localization of Fbxl7 in a *ftΔD* background. When a heteroallelic combination of null *ft* alleles, *ft*^*Grv*^*/ft*^*8*^, is rescued by a wild-type version of *ft (ft*^*+*^*)*, wings are normal ([Figure 5D](#fig5){ref-type="fig"}) and Fbxl7 displays normal apical localization ([Figure 5D′--D‴](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). However, apical localization of Fbxl7 is markedly reduced in *ft*^*Grv*^*/ft*^*8*^; *ftΔD* ([Figure 5E′--E‴](#fig5){ref-type="fig"}). We also examined a different deletion, *ftΔF*, in which wings from these flies are not enlarged but have greatly reduced spacing between the cross veins ([Figure 5F](#fig5){ref-type="fig"}). In *ft*^*Grv*^*/ft*^*8*^; *ftΔF* imaginal discs, the apical localization of Fbxl7 is not disrupted ([Figure 5F′--F‴](#fig5){ref-type="fig"}). Similarly in *ft*^*61*^ clones, which display strong overgrowth, Fbxl7 localization was normal ([Figure 5G--G″](#fig5){ref-type="fig"}). Thus, the apical localization of Fbxl7 requires the Ft D domain but neither the F domain nor the motif that is disrupted by the *ft*^*61*^ allele.

To examine whether the effects on Fbxl7 localization in vivo correlated with the ability of Fbxl7 to physically interact with Ft, we tested the ability of these mutant Ft proteins to co-immunoprecipitate with FLAG-Fbxl7 ([Figure 5H](#fig5){ref-type="fig"}). Indeed, Ft^61^ and FtΔF proteins co-immunoprecipitated at levels comparable to wild-type Ft. However, the level of FtΔD in FLAG-Fbxl7 immunoprecipitates was greatly reduced, as was that of Ft^mutV^, a mutant Ft protein in which a cluster of 10 serine/threonine residues overlapping the D domain was mutated to alanines. These sites were identified as candidates for phosphorylation by Dco ([@bib46]). However, since Fbxl7 localizes normally in *dco* mutant clones, the inability of Fbxl7 to bind to Ft^mutV^ might be caused by a change in its conformation that does not depend on phosphorylation by Dco. Indeed *ft*^*Grv*^*/ft*^*8*^; *ft*^*mutV*^ flies also have phenotypic abnormalities that are very similar to those of *Fbxl7* mutants ([@bib46]).

To test for a functional relationship between the D domain of Fat and Fbxl7, we monitored apical levels of Ft, FtΔD, and FtΔF under conditions of Fbxl7 overexpression. Ft and FtΔF levels are increased in cells overexpressing Fbxl7, while FtΔD levels do not increase ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). This demonstrates that the D domain is required for Fbxl7 to physically interact with and exert its effects on Ft localization.

If Ft^61^ protein is still capable of recruiting Fbxl7 to its apical location, then overexpression of Fbxl7 might suppress the overgrowth observed in mutant discs. The overgrowth and lethality of a *ft* null background (*ft*^*Grv*^*/ft*^*8*^) can be rescued by ubiquitous expression of Ft ([@bib43]; [@bib5]; [@bib46]; [@bib75]; [Figure 5---figure supplement 3D,I](#fig5s3){ref-type="fig"}). While ubiquitous Fbxl7 expression was unable to suppress *ft*^*Grv*^*/ft*^*8*^ phenotypes ([Figure 5L](#fig5){ref-type="fig"}), the overgrowth and lethality of *ft*^*61*^/*ft*^*8*^ discs was indeed suppressed, resulting in viable adult flies ([Figure 5M,O](#fig5){ref-type="fig"}). *dco*^*3*^ and *wts* mutant cells in the eye imaginal disc are overgrown and express higher Diap1 levels, an indicator of Yki activity ([Figure 5P--P′](#fig5){ref-type="fig"}, [Figure 5---figure supplement 3L--N′](#fig5s3){ref-type="fig"}). Fbxl7 overexpression can rescue both clone size and Diap1 levels in *dco*^*3*^ mutant cells ([Figure 5Q--Q′](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1O--O′](#fig5s1){ref-type="fig"}), but not *wts* clones ([Figure 5---figure supplement 3M--M′](#fig5s3){ref-type="fig"}). Thus, mutant Ft^61^ protein, or Ft protein that cannot be phosphorylated by Dco, can still bind to Fbxl7 and facilitate the growth-suppressive functions of Fbxl7. Taken together, these findings implicate Fbxl7 in one of two growth-suppressive pathways downstream of Ft and suggest that these two pathways might converge further downstream ('Discussion').

Fbxl7 regulates the localization of the atypical myosin Dachs {#s2-6}
-------------------------------------------------------------

Since Ft and Fbxl7 localized preferentially to the proximal side of cells, we compared the localization of Fbxl7 with that of D. In confocal z-sections, D and Fbxl7 co-localize at the subapical membrane in puncta, apical to the adherens junction marker Armadillo (Arm) ([Figure 6A--A‴](#fig6){ref-type="fig"}). However, careful examination of these puncta in x-y sections shows that the Fbxl7 and D puncta are slightly offset in the proximodistal direction ([Figure 6B--B′](#fig6){ref-type="fig"}). D is localized at higher levels at the distal edge of the cell ([@bib38]; [@bib8]) where it is likely stabilized by physical interaction with the cadherin Ds ([@bib6]). Therefore, a likely explanation is that the formation of multimeric Ft--Ds complexes between cells results in the concomitant accumulation of Fbxl7 at the FatICD and D at the DsICD ([Figure 6C](#fig6){ref-type="fig"}).10.7554/eLife.03383.011Figure 6.Fbxl7 regulates the localization of Dachs.(**A**--**A″**) Confocal slice through a bend in the wing disc showing (**A′**) Dachs (red) and (**A″**) Fbxl7 (green) localize at subapical membrane. (**A‴**) Like Fbxl7, Dachs is apical to the adherens junction marked by Arm (blue). (**B**--**B′**) Confocal slice through the apical surface of the wing disc, specifically the dorsal edge of the pouch, showing Dachs (red) and Fbxl7 (green) staining. Dachs and Fbxl7 puncta abut each other on either side of the cell boundary. Proximodistal axis indicated as P\<−\>D. (**C**) Diagram of polarized wing disc cells in which Dachs is enriched on the distal side and Fbxl7 is on the proximal side, linked by their association to Dachsous and Fat, respectively, which bind across cells. (**D--D″**) Apical confocal slice of MARCM *Fbxl7*^*Q201X*^ clones (green) and staining for Dachs (red) and Arm (blue). Dachs levels are elevated in clones. (**E**--**G**) Apical confocal slice with staining for Dachs in (**E**) wild-type or (**F**) *Fbxl7*^*Q201X*^ discs. Images are from the dorsal edge of the pouch and are aligned so the proximodistal axis is vertical. Dachs enrichment on P/D membrane, seen in (**E**) wild-type discs, is impaired in (**F**) *Fbxl7*^*Q201X*^ discs. (**G**) Quantification of Dachs P/D enrichment in wing discs. Dachs is localized in a P/D direction, whereas Actin is not. Dachs P/D asymmetry is impaired in both *Fbxl7*^*C616Y*^ and *Fbxl7*^*Q201X*^ discs. Significance calculated with one-way ANOVA test. \*\*\*p ≤ 0.001, \*p ≤ 0.05. Error bars indicate SD. (**H**--**H″**) Apical confocal slice of FLAG-Fbxl7 overexpressing clones (red, cells marked by RFP) and staining for anti-GFP (green, Dachs:GFP) and E-cad (blue). Apical Dachs levels within the clone are reduced, and Dachs is enriched at the edge of the clone. (**I**--**I‴**) Confocal z-section of a wing disc with a FLAG-Fbxl7 expressing clone (green) and stained for Dachs (red). FLAG-Fbxl7 and Dachs co-localize to apical membrane (arrow) and intracellular puncta (arrowheads). (**I″**--**I‴'**) Cytoplasmic levels of Dachs are slightly elevated within the clone. (**I‴**) Heat map of **I″**. (**J**) Western blots from wing disc lysates. Endogenous Dachs protein levels are not changed in *Fbxl7* mutant wing discs compared to control.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.011](10.7554/eLife.03383.011)10.7554/eLife.03383.012Figure 6---figure supplement 1.Additional Dachs tissue staining and Dachs levels in wing discs and S2 cells.(**A**--**A′**) Confocal slice through apical membrane of a clone expressing FLAG-Fbxl7 (green) in the wing disc and staining for Dachs (red). In wild-type cells bordering the clone, Dachs is enriched at the boundary. Puncta of Dachs in wild-type cells are apposed across the boundary with puncta of FLAG-Fbxl7 in overexpressing clones (arrowheads). (**B**--**C**) Confocal slice through apical membrane of *ft*^*61*^ clones (green, marked by GFP) and stained for anti-Dachs (red) and anti-Arm (blue). Arrowheads indicate edge of clone. (**B**) Dachs levels are higher in *ft*^*61*^ clones. (**C**) Overexpression of FLAG-Fbxl7 in *ft*^*61*^ clones reduces apical Dachs levels, to levels comparable to neighboring wild-type cells. Dachs levels are enriched at the edges of the clone. (**D**) Additional western of endogenous Dachs protein in dissected wing discs. Dachs protein levels do not change in *Fbxl7* mutant, *Fbxl7* overexpressing, or *ft* mutant backgrounds compared to control. (**E**) Western analysis of transfected Dachs-V5 protein levels in S2 cells. Transfecting increasing doses of FLAG-Fbxl7 does not change Dach-V5 levels.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.012](10.7554/eLife.03383.012)

To investigate whether Fbxl7 can regulate the levels or localization of D, we first examined *Fbxl7* mutant clones. The levels of apical D are increased throughout the clone ([Figure 6D--D″](#fig6){ref-type="fig"}) although not to the extent that occurs in *ft* clones. Thus Fbxl7 negatively regulates the level of D at the apical membrane. To determine whether Fbxl7 has a role in generating or maintaining the asymmetrical distribution of D, we examined the distribution of D in *Fbxl7* mutant wing discs. In these experiments, the distal edge of one cell cannot be distinguished from the proximal edge of its neighbor. However, in wild-type cells, endogenous D is preferentially observed on the proximal/distal edges and is found at lower levels at the other edges ([@bib8]; [Figure 6E,G](#fig6){ref-type="fig"}). In *Fbxl7*^*C201X*^ and *Fbxl7*^*C616Y*^ homozygotes, this bias in the distribution of D within the cells is reduced ([Figure 6F--G](#fig6){ref-type="fig"}), indicating that Fbxl7 also has a role in regulating the asymmetric localization of D.

We examined the localization of Dachs-GFP in clones that overexpressed *Fbxl7*. In these clones there was reduction in the overall levels of apical D ([Figure 6H--H″](#fig6){ref-type="fig"}). In addition, Dachs-GFP puncta ([Figure 6H--H″](#fig6){ref-type="fig"}) or endogenous D ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}) in neighboring wild-type cells are enriched against the border with *Fbxl7* overexpressing cells, and are aligned with puncta containing FLAG-Fbxl7, reminiscent of Ds staining in [Figure 4E--E″](#fig4){ref-type="fig"}. This likely resulted from the elevated levels of Ft in *Fbxl7*-overexpressing clones, which would cause an enrichment of Ds (and hence D) on the surface of wild-type cells contacting the clone. In z-sections, we observed subtle changes in the localization of D within the clone itself ([Figure 6I--I‴](#fig6){ref-type="fig"}). There was a slight increase in D throughout the cell, possibly at the expense of some of the bright puncta that are normally observed at the apical region. Furthermore, overexpressing Fbxl7 can rescue the higher apical Dachs levels seen in *ft*^*61*^ clones ([Figure 6---figure supplement 1B--C](#fig6s1){ref-type="fig"}). Thus, overexpression of *Fbxl7* may cause a shift in the overall distribution of D from the apical region to the interior of the cell.

Changing Fbxl7 levels does not alter the levels of Dachs ubiquitylation {#s2-7}
-----------------------------------------------------------------------

To determine whether Fbxl7 functions as part of an SCF-type ubiquitin ligase, we first tested whether Fbxl7 was capable of interacting with either SkpA or Cul1. In co-transfection experiments in S2 cells, robust interactions were observed in both cases indicating that Fbxl7 likely functions as part of an SCF complex ([Figure 7A](#fig7){ref-type="fig"}). Furthermore, when Fbxl7 was cotransfected with HA-tagged ubiquitin, and ubiquitylated proteins immunoprecipitated with anti-HA, a high molecular weight smear above the size of wild-type Fbxl7 was observed indicating that Fbxl7 is ubiquitylated under these conditions ([Figure 7B](#fig7){ref-type="fig"}). This is expected, as F-box proteins that function in SCF complexes are often themselves ubiquitylated ([@bib19]; [@bib73]). Interestingly, Fbxl7^C616Y^, which is incapable of binding to Ft, is also ubiquitylated suggesting that the incorporation of Fbxl7 into an active SCF complex does not require Ft.10.7554/eLife.03383.017Figure 7.Fbxl7 does not affect Dachs ubiquitylation, and Fbxl7 affects the localization of Cindr.(**A**) Co-immunoprecipitation assay from S2 cells. SkpA-HA and Cul1-HA immunoprecipitates with FLAG-Fbxl7. (**B**) In-vivo Fbxl7 ubiquitylation assay in S2 cells. FLAG-Fbxl7 and FLAG-Fbxl7^C616Y^ are ubiquitylated in vivo. (**C**--**D**) In-vivo Dachs ubiquitylation assay in S2 cells. Dachs-V5 is ubiquitylated under wild-type conditions, and does not change with (**C**) overexpression of FLAG-Fbxl7 or (**D**) knockdown of Fbxl7 with two different dsRNAs. (**E**--**E″**) Confocal slice showing localization of FLAG-Fbxl7 (red) and GFP-Cindr (green) in puncta (arrowheads). (**F**) Confocal slice through a bend in the wing disc. GFP-Cindr (green) localizes to subapical membrane, apical to E-cad (red). Asterisk indicates an adjacent bend in the tissue. (**G**) Co-immunoprecipitation experiment in S2 cells. Cindr-V5 pulls down with full length FLAG-Fbxl7, and FLAG-Fbxl7Δ2, which contains only the LRR domains. (**H**--**I″**) Confocal slice in a disc with clones overexpressing FLAG-Fbxl7 (red, cells marked by myr-RFP) in a *GFP-Cindr* background. (**H**--**H″**) An apical plane shows loss of apical GFP-Cindr within the clone, and (**I**--**I″**) a basal plane shows accumulation of GFP-Cindr in puncta. (**J**) Compared to (**J**) *nb\>FLAG-Fbxl7* alone, (**K**) overexpressing GFP-Cindr partially rescues the small wing phenotype. (**L**) Merge shows **J** blue and **K** in red. (**M**) Model of Fbxl7 as a component of Fat signaling. Not drawn to scale.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.017](10.7554/eLife.03383.017)10.7554/eLife.03383.018Figure 7---figure supplement 1.Additional analysis of Dachs ubiquitylation, vesicle markers, and Cindr.(**A**) In-vivo ubiquitylation assay of Dachs-V5 from imaginal discs. Expressing FLAG-Fbxl7 does not alter ubiquitylation of Dachs-V5. (**B**) Knockdown of endogenous Fbxl7 and (**C**) knockdown of transfected FLAG-Fbxl7 by two different dsRNAs (DRSC15553, DRSC38270) in S2 cells. (**D**) In-vivo ubiquitylation assay of Dachs-V5 from S2 cells. Expressing Cul1^DN^ does not affect Dachs-V5 ubiquitylation. (**E**--**J″**) Confocal slice showing localization of FLAG-Fbxl7 (red) and a vesicle marker (green) in the wing disc. Fbxl7 does not colocalize with a marker of the (**E**) ER (GFP-KDEL), (**F**) trans-Golgi (GFP-Galt), or (**G**) early endosomes (GFP-FYVE). (**H**--**I″**) Fbxl7 partially colocalizes with (**H**--**H″**) Snx3-GFP and (**I**--**I″**) Vps35-myc in vesicles. Insets shows magnification of vesicles with overlap. (**J**--**J″**) Confocal section through the apical surface of a wing disc expressing UAS-Fat (marked with mRFP) in the posterior compartment (*engrailed-Gal4*) in a *GFP-Cindr* (green) background and staining for E-cadherin (blue). GFP-Cindr apical localization is unchanged with Fat overexpression. (**K**) Genetic interaction of Fbxl7 and Cindr experiment and quantification of adult wing size from expression of genes in the wing pouch (*nb-Gal4*). *UAS-GFP-Cindr* overexpression partially rescues the small wing due to *UAS-FLAG-Fbxl7* overexpression. *UAS-GFP-Cindr* expressing wings are wild type in size. (**L**--**M**) Compared to (**L**) control *nb-Gal4* wings, (**M**) overexpressing *GFP-Cindr* causes wings to be rounder and crossveins closer (arrows). (**O**) Quantification of reduced crossveins of *GFP-Cindr* overexpressing wings. (**K** and **O**) Significance calculated with 1way ANOVA followed by Tukey\'s test. n ≥ 10 wings. \*\*\*p ≤ 0.001. Error bars indicate SD.**DOI:** [http://dx.doi.org/10.7554/eLife.03383.018](10.7554/eLife.03383.018)

Since Fbxl7 may function as a component of an E3 ubiquitin ligase, the most parsimonious explanation of its function would be that Fbxl7 ubiquitylates Dachs directly and promotes its degradation by the proteasome. However, the overall levels of D are unchanged in *Fbxl7* mutant discs ([Figure 6J](#fig6){ref-type="fig"}), discs that overexpress Fbxl7, or *ft* mutant discs as assessed by Western blotting ([Figure 6---figure supplement 1D](#fig6s1){ref-type="fig"}). In addition, increasing doses of transfected FLAG-Fbxl7 in S2 cells does not affect total levels of Dachs-V5 ([Figure 6---figure supplement 1E](#fig6s1){ref-type="fig"}). If at all, a slight increase in Dachs-V5 levels was observed. Since Fbxl7 is localized apically and preferentially localizes to the proximal edge of the cell, Fbxl7 could promote D degradation locally and this may not be reflected in the overall levels of D.

We therefore tested whether Fbxl7 was capable of promoting D ubiquitylation. These experiments were conducted in both S2 cells and imaginal discs. Ubiquitylated D was readily detected. However, the level of ubiquitylation was unchanged when Fbxl7 was increased ([Figure 7C](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}). Additionally, we reduced Fbxl7 in S2 cells by RNAi-mediated knockdown using two different dsRNAs and still observed no change in D ubiquitylation ([Figure 7D](#fig7){ref-type="fig"}). Importantly, we observe knockdown of Fbxl7 protein in S2 cells using these dsRNAs ([Figure 7---figure supplement 1B--C](#fig7s1){ref-type="fig"}). Furthermore, expressing a dominant negative version of Cul1 (Cul1^DN^) does not impair D ubiquitylation ([Figure 7---figure supplement 1D](#fig7s1){ref-type="fig"}), implying that the SCF complex may not be involved. Thus we have no evidence that Fbxl7 influences D ubiquitylation.

Fbxl7 co-localizes with Cindr and displaces it from the apical membrane {#s2-8}
-----------------------------------------------------------------------

If Fbxl7 negatively regulates the accumulation of D at the apical membrane, it may do so by promoting the trafficking of D into intracellular vesicles. Indeed, we observed a population of intracellular puncta, likely vesicles, that contain both Fbxl7 and D ([Figure 6I--I″](#fig6){ref-type="fig"}). Moreover Fbxl7 overexpression can cause an overall shift in D from the apical membrane to the interior of the cell ([Figure 6I‴](#fig6){ref-type="fig"}). To further characterize the population of vesicles that contain Fbxl7, we examined the localization of FLAG-Fbxl7 with 59 different markers that each labeled a subpopulation of vesicles and with several proteins that have been identified as interactors of Ft in proteomic studies ([@bib33]) ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). No co-localization was observed with most of these markers ([Figure 7---figure supplement 1E--G](#fig7s1){ref-type="fig"} as examples) and partial co-localization was seen with two markers of the retromer pathway, Snx3 and Vps35 ([Figure 7---figure supplement 1H--I″](#fig7s1){ref-type="fig"}). However, strong co-localization was seen with a protein-trap insertion of GFP in the *cindr* locus. Cindr is thought to be an adapter protein that links membrane proteins to the actin cytoskeleton ('Discussion'). In basal sections, there is almost complete overlap between GFP-Cindr and FLAG-Fbxl7 in puncta ([Figure 7E--E″](#fig7){ref-type="fig"}). GFP-Cindr is normally localized to the subapical membrane, apical to E-cadherin, but its localization there is less punctate and more diffuse than that of FLAG-Fbxl7 ([Figure 7F](#fig7){ref-type="fig"}). When tagged versions of both proteins were expressed in S2 cells, Cindr co-immunoprecipitated with full length Fbxl7 or with a version containing only the LRRs (Fbxl7Δ2) ([Figure 7G](#fig7){ref-type="fig"}).

To determine whether Fbxl7 could influence the cellular localization of GFP-Cindr, we overexpressed FLAG-Fbxl7 in clones in *GFP-Cindr* animals. In these clones, we observed a dramatic re-localization of GFP-Cindr. GFP-Cindr is almost entirely eliminated from the apical membrane ([Figure 7H--H″](#fig7){ref-type="fig"}) and increased numbers of basally located vesicles are observed ([Figure 7I--I″](#fig7){ref-type="fig"}). Thus, Fbxl7 is capable of displacing a protein associated with the apical membrane into intracellular vesicles. Importantly, this is unlikely to be a consequence of increased Ft in the apical membranes of Fbxl7-ovexpressing cells, since increasing Ft levels has no effect on the apical localization of GFP-Cindr ([Figure 7---figure supplement 1J--J″](#fig7s1){ref-type="fig"}). We next tested whether changes in Cindr levels are capable of modifying Fbxl7 phenotypes. Indeed we find that the reduction in wing size from overexpression of Fbxl7 was suppressed by co-expression of GFP-Cindr ([Figure 7J--L](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1K](#fig7s1){ref-type="fig"}). Overexpression of GFP-Cindr alone causes slightly rounder wings with closer crossveins, though these wings were not significantly overgrown ([Figure 7---figure supplement 1L--O](#fig7s1){ref-type="fig"}).

Under conditions of Fbxl7 overexpression, we did not observe any increase in Cindr ubiquitylation indicating that Cindr is unlikely to be a direct target of Fbxl7 (not shown). Moreover, reducing Cindr levels by RNAi did not elicit phenotypic abnormalities in wings suggestive of defects in Ft or D (not shown). However, the ability of Fbxl7 to cause changes in the localization of Cindr and Ft indicates that it can regulate trafficking of proteins between the apical membrane and the interior of the cell in either direction, and the pathways that regulate the trafficking of these proteins and D might share common components. Some of these shared components could potentially be direct targets of Fbxl7 ubiquitylation.

Discussion {#s3}
==========

The protocadherin Ft lies at the apex of multiple pathways that together regulate growth, several aspects of PCP, and proximodistal patterning. The mechanism by which Ft functions as a signaling molecule remains poorly understood. We have now identified the F-box protein Fbxl7 as an immediate effector of Ft, that functions to restrict the levels of the atypical myosin D at the apical membrane as well as its distribution around the perimeter of the cell. In addition, Fbxl7 can regulate levels of Ft at the apical membrane.

Multiple effector pathways downstream of fat {#s3-1}
--------------------------------------------

Recent studies have revealed that Ft\'s effects on distinct pathways may be genetically separated, and that multiple effector domains can contribute to the same function. Indeed, the growth-suppressing function of Ft may occur via at least two regions of the Ft ICD. One or more regions between amino acids 4834 and 4899 in full-length Ft appear responsible for Ft's ability to regulate Hippo signaling (labeled HM in [Figure 7M](#fig7){ref-type="fig"}) ([@bib43]; [@bib5]; [@bib75]). Several mutations within this region compromise this function of Ft and cause massive tissue overgrowth ([@bib5]). Intriguingly, an allele of *ft*, *ft*^*61*^, which harbors such a mutation, showed neither an effect on the recruitment of Fbxl7 to the apical membrane nor on the binding of Ft to Fbxl7. Thus, signaling via this region of the ICD appears to be independent of Fbxl7. A second, more C-terminal region of the Ft ICD (Region D in [Figure 7M](#fig7){ref-type="fig"}) that extends between amino acids 4975 and 4993 of full-length Ft, is removed by the *ftΔD* deletion and also has a growth-suppressive function albeit weaker than that of HM ([@bib46]). This second growth-suppressive pathway requires the function of Fbxl7, as the protein generated by the *ftΔD* allele cannot bind to Fbxl7 nor can it localize Fbxl7 to the apical membrane. Additionally, the phenotypic abnormalities of null alleles of *ft* rescued by *ftΔD* are very similar, if not identical to those of *Fbxl7* mutants. Furthermore, like *ftΔD, Fbxl7* mutations do not display overt abnormalities of hair orientation in the wing ([Figure 1---figure supplement 2E--J](#fig1s2){ref-type="fig"}), or abdomen (not shown).

We have shown that hyperactivation of the "weaker" Fbxl7-dependent pathway can overcome the absence of the 'stronger' Fbxl7-independent pathway; overexpression of Fbxl7 can suppress the overgrowth of *ft*^*61*^. Thus, while these two pathways can be dissociated at the level of the Ft ICD, they nevertheless seem to converge further downstream. This point of convergence likely involves D since the overgrowth of *ft* mutant tissue can be suppressed completely by eliminating D function ([@bib12]). Indeed, it has previously been suggested that Ft regulates growth by restricting the levels of apical D, and regulates PCP by influencing the planar asymmetry of apical D ([@bib51]; [@bib46]).

Another key finding in our experiments is that *Fbxl7* mutations perturb the distribution of D around the perimeter of the apical region of the cell. D is normally biased towards the distal edge of the cell; in *Fbxl7* mutants, D is more evenly distributed around the cell perimeter. The asymmetric localization of D depends on at least two different regions of Ft ([@bib46]). One is the region that binds to Fbxl7 (Region D) and the other is composed of the last three amino acids at the C-terminus of the protein (Region F in [Figure 7M](#fig7){ref-type="fig"}), which is not necessary for Fbxl7 localization to the apical membrane. Thus, for the regulation of D asymmetry as well, there appears to be an Fbxl7-independent pathway. The existence of multiple downstream effector pathways that converge on common biological outcomes suggests that these pathways might function redundantly to some extent and thus provide robustness. This might also explain why the phenotypes elicited by overexpression of Fbxl7 are, in general, more severe than those observed in loss-of-function mutations.

Fbxl7 as a regulator of protein localization {#s3-2}
--------------------------------------------

Previous observations of the localization of Ft, Ds, and D to vesicles are suggestive of trafficking events being involved in Ft signaling ([@bib35]; [@bib40]; [@bib38]). We have demonstrated that, in addition to the apical membrane, Fbxl7 localizes to vesicles. Moreover, FLAG-Fbxl7 vesicles can contain Ft, Ds and D, and these may be related to the apical puncta observed on cell edges. This localization is likely specific, since we do not see Fbxl7 co-localization with other cell surface proteins such as Crumbs, Notch, and E-cadherin (not shown). Currently very little is known about the role of each of these proteins in vesicles. However, there is an increasing appreciation that most transmembrane proteins, and even proteins that are associated with the inner leaflet of the cell membrane are maintained at the plasma membrane by a dynamic process involving endocytosis and vesicle recycling (e.g., [@bib52]).

We provide evidence that Fbxl7 regulates Ft apical localization, but how this regulation relates to the Fbxl7 phenotypes is not clear. Since Fbxl7 overexpression increases Fat signaling, and rescues the overgrowth-inducing Ft^61^ allele, perhaps this is due to the increased levels of Ft protein at the apical membrane. However, Ft levels are slightly elevated in *Fbxl7* mutants, which display mild overgrowth. Therefore the mutant phenotype cannot be explained by the effect on Ft. Another known regulator of apical Ft levels is *lowfat* (*lft*) ([@bib37]). Fbxl7 and Lft appear to regulate Ft in different ways. Lft overexpression, like Fbxl7, increases Ft levels. However, while Ft levels are decreased in *lft* mutant cells, Ft levels are increased in *Fbxl7* mutant cells, though less so compared to *Fbxl7* overexpression. Interestingly, for many proteins that regulate cellular trafficking, similar phenotypic abnormalities are observed with gain-of-function and loss-of-function mutations, since the normal execution of the process requires the protein to shuttle efficiently between two states ([@bib47]). Thus dynamic aspects of the localization of Ft, Ds and D clearly merit more attention.

The interactions we have observed between Fbxl7 and the adapter protein Cindr may provide clues for how Fbxl7 regulates D localization. Fbxl7-associated vesicles show almost complete overlap with GFP-Cindr and Fbxl7 can re-localize Cindr from the apical membrane to the interior of the cell. This finding, together with the observed increase in basal levels of D upon Fbxl7 overexpression ([Figure 6I--I‴](#fig6){ref-type="fig"}), suggests that Fbxl7 may function to regulate D trafficking in a similar manner. Cindr and its mammalian orthologues Cin85 and CD2AP are thought to regulate interactions between membrane proteins and actin cytoskeleton ([@bib21]; [@bib48]; [@bib59]; [@bib28], [@bib27]). D is an atypical myosin with a predicted actin binding domain in its conserved head domain. Therefore, the vesicles which Fbxl7 associates with D and Cindr may be linked to the actin cytoskeleton. In addition, our finding of partial colocalization of Fbxl7 with retromer components further supports the possibility that Fbxl7 may have a role in protein trafficking.

Fbxl7 as a ubiquitin-ligase component {#s3-3}
-------------------------------------

Many F-box proteins associate with Skp1 and Cul1 to form an SCF E3 ubiquitin ligase complex (reviewed in [@bib57]). Recruitment of specific substrates results in their poly-ubiquitylation and degradation, or mono-ubiquitylation, which can have non-degradative signaling roles. In addition, some F-box proteins have SCF-independent roles ([@bib44]). Fbxl proteins are thought to recruit substrates to the SCF complex through the interaction with their LRR domains, and substrates have been identified for several Fbxls such as Skp2 (Fbxl1), which degrades p27 ([@bib11]; [@bib61]). However many, like Fbxl7, are still uncharacterized as 'orphan' F-box proteins with no known substrates.

Since we find that Fbxl7 associates with Skp1 and Cul1, its potential substrates may be involved in Ft signaling. Fbxl7 has one described substrate in mice, Aurora A ([@bib14]). However we do not believe Aurora A is a relevant substrate in *Drosophila*, as we do not observe Ft signaling defects when Aurora A is knocked down or overexpressed (not shown). The identification of F-box protein substrates has mainly been accomplished by unbiased approaches ([@bib57]). Similarly, a combination of unbiased approaches, involving proteomics, genetic interaction screens, and identifying proteins that co-localize with Fbxl7 in vesicles could be used to identify Fbxl7 substrates.

Materials and methods {#s4}
=====================

*Drosophila* genetics {#s4-1}
---------------------

*Fbxl7*^*C616Y*^ and *Fbxl7*^*Q201X*^ alleles were isolated in two EMS screens, *Fbxl7*^*W389X*^ was found fortuitously in a separate fly stock, and *Fbxl7*^*MI04292*^ (BL37813) is a *MI{MIC}* insertion in the first intron of *Fbxl7*. All *Fbxl7* alleles are on chromosomes bearing a *FRT82B* insertion. *Fbxl7* overexpression stocks used were *UAS-FLAG-Fbxl7* (this study, attP40 and attP2), *UAS-FLAG-Fbxl7*^*C616Y*^ (this study, attP40), and *P{XP}CG4221*^*d08178*^ (BL19289). *Fbxl7* RNAi stocks used were *UAS-Fbxl7*^*RNAi*^ (JF01515 \[BL31065\], VDRC108628). All RNAi experiments performed in flies used UAS-Dcr2, which increases knockdown. The *fat*^*61*^ allele was isolated in an EMS screen for supercompetitor mutations (T4854I amino acid change).

Additional stocks used were: *FRT82B dco*^*le88*^ ([@bib30]), *P\[acman\]-Fat+; P\[acman\]-FatΔD*, *P\[acman\]-FatΔF* ([@bib46]), *Diap1 3.5-GFP* ([@bib74]), *FRT42D fj*^*N7*^, *FRT40A ft*^*Grv*^, *FRT40A ds*^*38k*^, *UAS-Fat* ([@bib55]), *yki*^*B5*^ ([@bib25]), *Tub-EGFP.ban* ('bantam sensor', [@bib7]), *FRT40A*, *FRT82B* ([@bib71]), *UAS-GFP-cindr-PC* ([@bib29]), *Dachs-GFP* ([@bib6]).

Remaining stocks used were from, or derived from, the Bloomington Stock Center (Bloomington, IN): *UAS-dcr2; nub-Gal4* (BL25754), *eyFLP; FRT82B ub-GFP* (BL5580, BL5188), *FRT82B ub-RFPnls* (BL30555) *hsFLP;; Act\>CD2\>Gal4 UAS-GFP* (BL26902, BL4780), *FRT82B MARCM* (BL30036), *FRT40A MARCM* (BL5192), *FRT40A ex*^*e1*^ (BL44249), *FRT82B wts*^*X1*^ (BL44251), *FRT82B dco*^*3*^ (BL44250), *FRT40A d*^*GC13*^ (BL28289), *UAS-d:v5* (BL28291), *UAS-zyx-ChRFP* (BL28875), *UAS-fj:V5* (BL44252), *Df(3R)BSC515* (BL25019), *Df(3R)BSC728* (BL26580), *GFP-Cindr*^*CA06686*^ (BL50802), *act-Gal4* (BL3954), *tub-Gal4* (BL5138), *FRT40A ft*^*8*^ (BL44257), *hs-Gal4* (BL1799), *UAS-EGFP* (BL6658), *UAS-myr-mRFP* (BL7119), *UAS-GFP-KDEL* (BL9898), *UAS-Galt-GFP* (BL30902), *UAS-GFP-myc-2xFYVE* (BL42712), *eyFLP; 40A CL white+/CyO* (BL5622), *en-Gal4 UAS-RFP* (BL30557).

Stocks used for vesicle co-localization are listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} and are listed with BL numbers if available.

Tissue immunohistochemistry {#s4-2}
---------------------------

*hsFLP*-induced clones were generated by incubating larvae at 37°C at 48 hr after egg deposition (AED). A 30-min incubation was used for experiments using *Act\>CD2\>Gal4* and 2-hr incubation for experiments using *MARCM*. Immunostainings were performed by dissecting imaginal discs from wandering third instar larvae, fixing discs in 4% paraformaldehyde + PBS, followed by blocking in PBS + 0.1% Triton-X + 5% normal goat serum (NGS), incubation with primary antibodies overnight at 4°C, and incubation with secondary antibodies overnight at 4°C. Immunostainings with anti-Fbxl7 antibodies required a separate optimized protocol: Larvae were dissected in 0.1 M NaPO~4~, fixed in PLP-fixative (2% paraformaldehyde, 0.01 M NaIO~4~, 0.075 M lysine, 0.037 M NaPO~4~), washed with 0.1 M NaPO~4~ containing 0.1% saponin, blocked with 0.1 M NaPO~4~ containing 0.1% saponin and 5% NGS, primary and secondary antibodies were diluted in 0.1 M NaPO~4~ containing 0.1% saponin and 5% NGS. Samples were imaged on a Zeiss 700 confocal microscope (Germany).

The anti-Fbxl7 antibody was generated by immunizing guinea pigs (Pocono Farms, Canadensis, PA) with purified Fbxl7 (amino acids 22--324) produced at the UC-Berkeley MacroLab (His-Fbxl7 purified on a Nickel column), and used at 1:1000 for tissue staining.

Other antibodies used: rat anti-Dachs (1:500, [@bib8]), rat anti-Fat (1:1600, [@bib18]), rat anti-Dachsous (1:5000, [@bib72]) rat anti-Ecad (1:100, DCAD2, DHSB, Iowa City, IA), mouse anti-FLAG (1:1000, F3165; Sigma, St. Louis, MO), rabbit anti-FLAG (1:1000, F7425; Sigma) mouse anti-V5 (1:500, R960-25; Invitrogen, Carlsbad, CA), mouse anti-Arm (1:100, N2 7A1; DHSB), rabbit anti-LacZ (1:500, \#559762; MP Biomedicals, Santa Ana, CA), anti-Cleaved Caspase-3 (1:200, 9661; Cell Signaling, Beverly, MA). Actin was visualized with Phalloidin-TRITC (1:500, Sigma) or Alexa Fluor 633 Phalloidin (1:500, Invitrogen). Nuclei were visualized with DAPI (1:1000).

Plasmids and molecular biology {#s4-3}
------------------------------

Plasmids were constructed using conventional ligation-based molecular cloning techniques. Oligonucleotide sequences are listed in a separate table in [Supplemental file 2](#SD2-data){ref-type="supplementary-material"}. Fbxl7 was amplified from clone LD38495 (DGRC, Bloomington, IN) by designing oligonucleotides to amplify the single predicted coding sequence CG4221-RA and add Not1 and Xba1 restriction sites. The Not1-Fbxl7-Xba1 PCR fragment was digested and ligated into pUAS-FLAG attB (adds an N-terminal FLAG tag) to generate pUAS-FLAG-Fbxl7 attB. The C616Y amino acid change was introduced by site directed mutagenesis, generating pUAS-FLAG-Fbxl7^C616Y^ attB. Transgenic flies were made from pUAS-FLAG-Fbxl7 attB and pUAS-FLAG-Fbxl7^C616Y^ attB using PhiC31 integration (BestGene, Chino Hills, CA), inserting into attP40 and attP2 landing sites.

Fbxl7 truncation plasmids were generated by amplifying Fbxl7Δ1 (389-772aa), Fbxl7Δ2 (445-772aa), and Fbxl7Δ3 (1-388aa) and ligating into pUAS-FLAG attB using Not1/Xba1. pUAS-FLAG-EGFP attB was generated by amplifying EGFP from pEGFPattB (K Basler) and cloning into pUAS-FLAG attB using In-Fusion (Clonetech, Mountain View, CA).

SkpA and Cul1 coding sequence were amplified from genomic DNA and clone LD20253 (DGRC), respectively. Not1/Xba1 sites were added to oligos that amplified SkpA, and Kpn1/Not1 was added for Cul1. PCR fragments were digested and ligated into pMT-HA (adds a C-terminal HA tag), generating pMT-SkpA-HA and pMT-Cul1-HA. dCul1^DN^ is a C-terminal truncation (1-451aa) which corresponds to 1-452aa of dominant negative human hCul1DN ([@bib70]) and was cloned into pMT-HA as for full length dCul1.

pMT-FatICD-V5 was generated by amplifying FatICD coding sequence from pUAS-FatICD-V5 (K. Irvine), adding Not1/Xba1 sites with oligos. PCR fragments were digested and ligated into pMT-V5/6xHis (Invitrogen). pMT-FatICDΔD-V5, pMT-FatICDΔF-V5, and pMT-FatICDmutV-V5 were generated by using the same oligos to amplify from pUAS-FatICDΔD-V5, pUAS-FatICDΔF-V5, and pUAS-FatICDmutV-V5 (Irvine), respectively. pMT-FatICD61-V5 was generated by site directed mutagenesis of pMT-FatICD-V5 to make the change T4854I.

pUAS-HA-Ub attB was generated by amplifying Ubi-p5E coding sequence from genomic DNA, adding an N-terminal HA tag with primers, and inserting into pUAS attB (K Basler).

pMT-cindr-V5 was generated by amplifying the longest predicted isoform cindr-RC from S2R+ cell cDNA, adding Not1/Xba1 sites, and ligating into pMT-V5/6xHis (Invitrogen).

Other plasmids used are pMT-Dco-V5 ([@bib31]), pUAS-Dachs-V5 ([@bib38]).

The sequence of oligos used are in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}.

Western analysis of wing discs and S2R+ cells, co-immunoprecipitation, and in vivo ubiquitylation assays {#s4-4}
--------------------------------------------------------------------------------------------------------

S2R+ cells were cultured and transfected using conventional techniques. S2R+ cells were cultured in Schneiders medium containing 10% FBS at 27°C, transfected with Effectene (Qiagen, Germany) in six-well dishes, and harvested 72 hr later. 500 µM CuSO4 was added 24 hr before harvesting to induce expression from plasmids with metalothionein promoters. For Co-IP and in vivo ubiquitylation assays, 50 µM MG132 (C2211; Sigma) was added to transfected cells four hours before harvesting to inhibit proteasome activity. For experiments using dsRNA, S2R+ cells were transfected with dsRNA ± plasmids and were harvested as needed for protocols described above.

Unless otherwise stated, wing discs or S2R+ cells were boiled in 1x or 2x SDS Sample buffer, run on 7.5% Mini-Protean TGX gels (Bio-Rad, Hercules, CA), and transferred to nitrocellulose membrane. Protein bands were detected with primary antibodies and secondary antibodies conjugated to HRP, and imaged using ECL detection reagent (RPN2232; Amersham, UK).

For co-IP assays, 50 µM MG132 (C2211; Sigma) was added to transfected cells 4 hr before harvesting to inhibit proteasome activity. Cells were washed once with ice cold PBS, and lysed in lysis buffer (20 mM HEPES 7.5 pH, 5 mM KCl, 1 mM MgCl2, 0.1% NP-40, 'Complete' EDTA free protease inhibitor tablet \[Roche, Switzerland\]). Insoluble material and nuclei were removed by centrifugation at 13,000×*g* for 30 min at 4°C, and soluble cell lysate was incubated with anti-FLAG M2 affinity gel (A2220; Sigma) overnight at 4°C. Beads were washed twice in lysis buffer and denatured by boiling in SDS sample buffer for 10 min. For SkpA, Cul1, and Cindr co-IP assays, to avoid detection of non-specific binding of transfected proteins to beads, FLAG-protein complexes were eluted off beads by incubating with 400 ng/µl 3x FLAG peptide (F4799; Sigma) for 30 min at 4°C.

For in vivo ubiquitylation assays, 50 µM MG132 was added to transfected cells 4 hr before harvesting. Cells were washed once with ice cold PBS, and proteins denatured by boiling in 100 µl 1% SDS in PBS for 10 min 400 µl of 0.5% BSA, 1%Triton-X, in PBS was added, and samples were sonicated, then centrifuged at 13,000×*g* for 10 min. Supernatant was diluted to 1 ml with 5% BSA, 1%Triton-X and incubated with anti-HA agarose beads (A2095; Sigma) overnight at 4°C. Beads were washed twice with 1%Triton-X in PBS and boiled in SDS sample buffer for 10 min. For in vivo ubiquitylation of Dachs-V5 from larval tissue, 12 hr before dissection larvae were heat-shocked at 37°C for 1 hr to induce UAS transgenes by hs-Gal4. 30 brain-eye-antennal complexes per genotype were dissected in Schneiders medium and incubated with 50 µM MG132 for 4 hr. Complexes were boiled, diluted, sonicated, and centrifuged as above. Supernatant was diluted to 1 ml with 5% BSA, 1%Triton-X and incubated with Protein G Sepharose (P3296; Sigma) for 1 hr at 4°C, replaced with Protein G Sepharose plus 1 µl mouse anti-V5 antibody (R960-25; Invitrogen) and incubated overnight at 4°C. Beads were washed twice with 1%Triton-X in PBS and boiled in SDS sample buffer for 10 min.

For experiments using dsRNA, S2R+ cells were transfected with dsRNA ± plasmids and were harvested as needed for protocols described above. dsRNA was generated by PCR amplifying DRSC15513 and DRSC38270 from genomic DNA, and GFP coding sequence from pattB-EGFP (K Basler), adding T7 sequence to forward and reverse primers, and in vitro transcribing dsRNA (AM1333; Megascript T7 Transcription Kit, Invitrogen).

For anti-Fat western blots from wing discs, 20 wing discs were dissected from third instar larvae in PBS and immediately boiled in 2x SDS Sample buffer. The amount loaded on gels was adjusted to load equivalent amounts of protein.

For anti-Dachs westerns from wing discs, 20 wing discs were dissected from third instar larvae in PBS and lysed in 1x RIPA buffer. Total protein was quantified (Micro BCA kit, 23235; Fisher, Hampton, NH) and adjusted equally among samples. Secondary antibodies conjugated to LiCor fluorescent dyes were used to detect protein bands using a LiCor Odessey imager (Lincoln, NE).

Western blots were probed with the following antibodies:

Guinea pig anti-Fbxl7 (1:1000), rat anti-Fat (1:25,000, K Irvine), rat anti-Dachs (1:5,000, D Strutt), mouse anti-Tubulin (1:100, E7; DHSB), mouse anti-FLAG (1:10,000, F3165; Sigma), mouse anti-V5 (1:5,000; R960-25, Invitrogen), rabbit anti-V5 (1:5000, V8137; Sigma) rabbit anti-HA (1:1,000, 3724; Cell Signaling), rabbit anti-Ub (1:1,000, Z0458; DakoCytomation, Carpinteria, CA), mouse anti-Lamin (1:100, ADL67.10; DHSB), goat anti-rat-HRP (112-035-003; Jackson, West Grove, PA), goat anti-rabbit-HRP (111-035-003; Jackson), goat anti-mouse-HRP (172-1011; BioRad), goat anti-guinea pig-HRP (106-035-003; Jackson), goat anti-rat-IR680 (926-68,076; Licor), goat anti-mouse-IR800 (827-08,364; Licor).

Quantification of dimensions of adult structures {#s4-5}
------------------------------------------------

Wings or legs were mounted onto slides using Canadian Balsam medium (Gary\'s Magic Mount) and imaged on a Leica transmitted light microscope (TL RCI, Germany). Wing area and cross vein distance was quantified in ImageJ. For cross veins, we measured the distance of a straight line drawn from intersection of the anterior cross vein and L4 to the intersection of the posterior cross vein and L4. Statistical significance between groups was determined by one-way ANOVA using (Tukey\'s or Dunnett\'s test).

Quantification of Dachs asymmetry in wing discs {#s4-6}
-----------------------------------------------

Quantifications were performed as in [@bib8] using ImageJ. Wing discs were immunostained for Dachs and F-actin and imaged under identical settings at 20x to determine P-D orientation, and at 63x to image the dorsal portion of the wing pouch where Dachs asymmetry is highest. Images were rotated so that the P-D axis of the wing pouch oriented vertically (90° and 270°). A cropped 24.8 × 24.8um (500 × 500px) square was used to quantify the mean fluorescence intensity of Dachs or actin along each cell edge while recording the angle of the cell edge relative to the P-D orientation. Cell edge data were measured using a 1 pixel width line. Mean fluorescence of cell edges oriented in the P-D orientation (45°--135°) or the A-P orientation (0°--45°; 135°--180°) was isolated into two different lists, which were each averaged. The ratio of mean fluorescence of the A-P orientation to P-D orientation gives the P-D/A-P localization. For example, asymmetric localization to the P-D sides of cells will give higher mean intensities on cell edges in the A-P orientation. Quantifications were performed on eight cropped boxes from different discs for each group. Statistical significance between groups was determined by one-way ANOVA using (Tukey\'s test).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "The Drosophila F-box protein Fbxl7 associates with the protocadherin Fat and regulates signaling via the Hippo pathway" for consideration at *eLife*. Your article has been favorably evaluated by K VijayRaghavan (Senior editor) and 3 reviewers, one of whom is a member of our Board of Reviewing Editors.

This manuscript describe Fbxl7 as a new component of the Hippo signalling pathway downstream of Fat, thus providing important insights into how this transmembrane protein signals to control growth. They investigate relationships between several proteins including Fat, Dachsous, Dachs, Dco and vesicle trafficking proteins such as Cindr. The experiments are very rigorous and thorough, employing multiple mutant alleles, RNAi lines, transgenes, antibodies and biochemical reagents. It seems quite clear that Fbxl7 functions downstream of Fat to regulate growth and controls the apical localization and abundance of Dachs, although its mechanistic links to Dco and Cindr are not entirely clear. The manuscript represents a huge amount of work and while there are some loose ends mechanistically, substantial efforts have been made to make conclusions without over-interpreting data or forcing results.

The reviewers all agreed that the work described in this paper was novel, important and appropriate for publication in *eLife*. The reviewers had a few experimental points that they felt would strengthen the paper, and several points that they felt could be improved/clarified in the Discussion before publication.

Experimental/image issues:

1\) The Western blots in [Figure 6J](#fig6){ref-type="fig"} are not great quality. The reviewers appreciate that there might be some technical issues with the Dachs antibody but if it can be improved it will make this result clearer and add value to the manuscript. At present, these Western blots look like they have been over-modified with software such as Adobe Photoshop.

2\) [Figure 5](#fig5){ref-type="fig"}: The staining of loss of Fbxl7 in *ft*^*GrV*^*/ft*^*8*^*; ftΔD* is not very clear compared to controls in D. Can this be improved?

3\) Can fat loss upregulate and mislocalize Dachs in the absence of Fbxl7? The authors suggest that Fbxl7 has a role mediating some of Fat\'s effects on Dachs levels and asymmetry, likely by binding Fat\'s D domain. They also argue that the F domain\'s effects on Dachs asymmetry are not mediated by Fbxl7, but this is only based on the finding that removing the F domain does not detectably change Fbxl7 binding. However, it is still possible that the F domain\'s effects are mediated by Fbxl7, especially since Fbxl7 has residual binding to Fat lacking the D domain. It would be helpful if they tested how important Fbxl7 is for Fat\'s effects on Dachs. Can a form of Fat deficient in Fbxl7 binding, such as ΔD, still improve Dachs in a fat mutant?

4\) The authors do not present any evidence that the D domain is required for Fbxl7\'s effects on Fat levels. Does Fbxl7 (gain or loss) affect the apical levels of FatΔD?

DISCUSSION POINTS

1\) Fat localization: The authors show a very strong (although complex) role of Fbxl7 controlling Fat localization. However, this role hardly gets mentioned in the Discussion, and so it is not at all clear how and if it connects to the Fbxl7 phenotype. In the Results, in contrast, the authors suggest that some of the effects of Fbxl7 are "amplified" by changing Fat levels, and that this effect is likely mediated through the D domain. More Discussion should be devoted to the alterations in Fat levels. A brief comparison to Lowfat is also probably in order, as Lowfat also regulates Fat levels.

2\) Fbxl2 overexpression: This causes a phenotype very similar to that of Dachs mutants, but only causes very subtle effects on Dachs localization. If much or all of Fbxl2\'s effects are mediated via Dachs, as the authors suggest, this requires a little explanation.

3\) I don\'t think we can conclude that Fbxl7 function is not related to the growth-suppressive function that is perturbed in *ft*^*61*^ alleles, just that its localization is not affected by the ft61 mutation. Indeed Fbxl7 function could be disrupted in ft61 alleles; perhaps a more likely scenario is that Fat61 protein binds to Fbxl7 but cannot modulate its activity because it fails to recruit an accessory protein that either modulates Fbxl7 activity or that is regulated by Fbxl7.

4\) The text relating to the blots in [Supplementary Figure 6B](#fig6s1){ref-type="fig"} states that Dachs levels do not go up when Fbxl7 is increased but they actually do look higher. This also seems to hold true in [Figure 7C](#fig7){ref-type="fig"}. However, in [Figure 7D](#fig7){ref-type="fig"}, Fbxl7 RNAi does not seem to affect Dachs levels.

5\) The final model figure is not useful, and is at times misleading. Particularly, the labeling of the regions 1,2 and 3 is not helpful, as it adds yet another unmatching set of designations to the Ft cytoplasmic domain. It would be more useful if the authors adapted [Figure 5](#fig5){ref-type="fig"} to their final model. Also, the arrows to Dachs might be better if they were dotted, or via question marks, or possibly across cell membranes to Ds, as all the data in their paper indicates that the link to Dachs is indirect.

6\) The manuscript gets a bit bogged down with the negative data about the possible type of vesicles, possible functions of Dachs and the inclusion of the Cindr data. The manuscript would be improved if this section of the paper was reduced, as it is largely negative data. Similarly, it would be more useful if the Discussion addressed what the authors have shown and their model, and reduce the discussion of vesicles and Cindr, as the link to the title and the Abstract is not carried through.
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Author response

Experimental/image issues:

*1) The Western blots in* [*Figure 6J*](#fig6){ref-type="fig"} *are not great quality. The reviewers appreciate that there might be some technical issues with the Dachs antibody but if it can be improved it will make this result clearer and add value to the manuscript. At present, these Western blots look like they have been over-modified with software such as Adobe Photoshop*.

The signals obtained in Western blots using the anti-Dachs antibody are always weak. We have done the experiment many times to satisfy ourselves that the results are consistent -- we never see a change in Dachs protein levels in Fbxl7 mutant discs, though the blots are never pretty because of the poor level of signal above background. We have replaced the blot used in the original [Figure 6J](#fig6){ref-type="fig"} with another one. That original blot is now in the supplemental figure (with less modification of brightness and contrast), we have retained it in the supplemental figure because it shows discs of additional genotypes as well.

*2)* [*Figure 5*](#fig5){ref-type="fig"}*: The staining of loss of Fbxl7 in* ft^GrV^/ft^8^; ftΔD *is not very clear compared to controls in D. Can this be improved?*

We had previously shown only confocal slices through a bend in the wing disc, which is used to show apically localized proteins. We now show the x-y images, and z-sections, which show very clearly that the levels at the apical membrane are reduced considerably.

3\) Can fat loss upregulate and mislocalize Dachs in the absence of Fbxl7? The authors suggest that Fbxl7 has a role mediating some of Fat\'s effects on Dachs levels and asymmetry, likely by binding Fat\'s D domain. They also argue that the F domain\'s effects on Dachs asymmetry are not mediated by Fbxl7, but this is only based on the finding that removing the F domain does not detectably change Fbxl7 binding. However, it is still possible that the F domain\'s effects are mediated by Fbxl7, especially since Fbxl7 has residual binding to Fat lacking the D domain. It would be helpful if they tested how important Fbxl7 is for Fat\'s effects on Dachs. Can a form of Fat deficient in Fbxl7 binding, such as ΔD, still improve Dachs in a fat mutant?

We are confused by the first sentence of this comment since loss of either Fbxl7 or loss of Fat already results in Dachs mislocalization. If the reviewers were wondering whether overexpression of Fbxl7 can rescue some of the Dachs defects in *ft* mutants, we have now added data to show that the increased Dachs levels in *ft*^*61*^ clones are suppressed by increasing Fbxl7 levels ([Figure 6--figure supplement 1B, C](#fig6s1){ref-type="fig"}). Please note that the Ft^61^ protein can still bind to and apically localize Fbxl7.

The reviewers also point out that the D-deletion does not completely abolish Fbxl7 binding to Ft and suggest that there might be residual binding via the F-domain. We have included additional data ([Figure 5--figure supplement 2](#fig5s2){ref-type="fig"}) that show that overexpression of Fbxl7 increases the apical levels of wild-type Ft and FtΔF but not FtΔD suggesting that Fbxl7 needs to bind to Ft via the D domain but not the F domain (at least by this assay). We think the presence of a low level of binding in the ΔD mutant may simply be that the D deletion only partially removes the site that binds Ft and may therefore reduce the binding affinity substantially. In the absence of structural information, this issue cannot be fully resolved.

It would be helpful if they tested how important Fbxl7 is for Fat\'s effects on Dachs. Can a form of Fat deficient in Fbxl7 binding, such as deltaD, still improve Dachs in a fat mutant?

Work published by the Irvine lab ([@bib46]) shows that the FtΔD mutant provides partial rescue of the Dachs localization defect. We have cited this work.

4\) The authors do not present any evidence that the D domain is required for Fbxl7\'s effects on Fat levels. Does Fbxl7 (gain or loss) affect the apical levels of FatΔD?

Thank you for suggesting this experiment. We have included additional data ([Figure 5--figure supplement 2](#fig5s2){ref-type="fig"}) that show very clearly that the D domain is necessary for observing an increase in apical Ft levels upon Fbxl7 overexpression and that the F domain is not.

DISCUSSION POINTS

*1) Fat localization: The authors show a very strong (although complex) role of Fbxl7 controlling Fat localization. However, this role hardly gets mentioned in the Discussion, and so it is not at all clear how and if it connects to the Fbxl7 phenotype. In the Results, in contrast, the authors suggest that some of the effects of Fbxl7 are "amplified" by changing Fat levels, and that this effect is likely mediated through the D domain. More Discussion should be devoted to the alterations in Fat levels. A brief comparison to Lowfat is also probably in order, as Lowfat also regulates Fat levels*.

We have added discussion of this issue. We emphasize that some of the effects of Fbxl7 overexpression could be mediated by an increase in the levels of apical Ft. However, the phenotypic abnormalities observed in Fbxl7 loss-of-function mutants are not likely to result from the small increase in apical Ft levels. We have included a comparison to Lowfat as suggested by the reviewers.

*2) Fbxl2 overexpression: This causes a phenotype very similar to that of Dachs mutants, but only causes very subtle effects on Dachs localization. If much or all of Fbxl2\'s effects are mediated via Dachs, as the authors suggest, this requires a little explanation*.

We have included additional data using a Dachs-GFP, which in combination with the images using the anti-Dachs antibody, shows very clearly that Dachs levels at the apical membrane are reduced when Fbxl7 levels are increased.

*3) I don\'t think we can conclude that Fbxl7 function is not related to the growth-suppressive function that is perturbed in* ft^61^ *alleles, just that its localization is not affected by the ft61 mutation. Indeed Fbxl7 function could be disrupted in ft61 alleles; perhaps a more likely scenario is that Fat61 protein binds to Fbxl7 but cannot modulate its activity because it fails to recruit an accessory protein that either modulates Fbxl7 activity or that is regulated by Fbxl7*.

We have written a more conservative concluding sentence to this paragraph: "Thus, the apical localization of Fbxl7 requires the Ft D domain but neither the F domain nor the motif that is disrupted by the *ft*^*61*^ allele."

*4) The text relating to the blots in* [*Supplementary Figure 6B*](#fig6s1){ref-type="fig"} *states that Dachs levels do not go up when Fbxl7 is increased but they actually do look higher. This also seems to hold true in* [*Figure 7C*](#fig7){ref-type="fig"}*. However, in* [*Figure 7D*](#fig7){ref-type="fig"}*, Fbxl7 RNAi does not seem to affect Dachs levels*.

We agree with the reviewers that Dachs levels go up slightly when Fbxl7 is overexpressed in S2 cells. We have added this observation to the text.

*5) The final model figure is not useful, and is at times misleading. Particularly, the labeling of the regions 1,2 and 3 is not helpful, as it adds yet another unmatching set of designations to the Ft cytoplasmic domain. It would be more useful if the authors adapted* [*Figure 5*](#fig5){ref-type="fig"} *to their final model. Also, the arrows to Dachs might be better if they were dotted, or via question marks, or possibly across cell membranes to Ds, as all the data in their paper indicates that the link to Dachs is indirect*.

Thank you for these suggestions. We have, as suggested by the reviewers, adapted [Figure 5](#fig5){ref-type="fig"} to the final model and modified the arrows as requested.

*6) The manuscript gets a bit bogged down with the negative data about the possible type of vesicles, possible functions of Dachs and the inclusion of the Cindr data. The manuscript would be improved if this section of the paper was reduced, as it is largely negative data. Similarly, it would be more useful if the Discussion addressed what the authors have shown and their model, and reduce the discussion of vesicles and Cindr, as the link to the title and the Abstract is not carried through*.

While we agree with the reviewer that the data in this section do not provide a clear answer as to the direct target of Fbxl7, we also think that these experiments provide some of the best hints for where its direct targets may function (i.e. in vesicle trafficking). By showing these data, we hope that other scientists who work on vesicle trafficking will take notice of the localization of Fbxl7 and make connections with other observations that might point to candidate targets. We therefore think that it is important that these results are retained in the manuscript.
